1. Mar 2026
    1. On 2020-09-30 18:25:51, user Holger Claus wrote:

      I am almost sure that the calculated UVC dose for the moving regimens of 2.13 and 0.66mJ/cm2 are wrong (much too low). The actual dose must be measured. Also deactivating 6log with 0.66mJ/cm2 is magnitudes outside of other research

    1. On 2020-12-02 21:30:36, user Alexis Rohou wrote:

      I was asked by a journal to review this manuscript. Below is my review

      ***

      This manuscript explores the observation that Thon rings visible in amplitude spectra of micrographs decrease in amplitude as a function of spatial frequency (distance from the origin in F space) and that this decrease is more pronounced in micrographs collected with larger objective lens defocus.

      Since the height of Thon rings from image of test specimens can be taken as an estimator of recoverable signal-to-noise ratio in experimental data recorded under identical conditions, this has led many practitioners to prefer to collect data as close to focus as possible. The dominant assumption in the field has been that the observed defocus-dependent contrast attenuation is due to imperfect spatial coherence of the electron source, but this manuscript provides compelling evidence that another phenomenon is responsible.

      The authors note that a significant amount of signal is delocalized beyond the edges of the field of view and so cannot be recovered. Further, the authors point out that single-sideband (SSB) signal in the collected image (be it from features in the field of view but near its edges, or delocalized from features not present in the field of view), while it contributes power to the image, does not contribute to Thon rings because its amplitude is not modulated by the CTF.

      I find the authors' evidence in support of this compelling:<br /> - experimentally, the nodes (local minima) between Thon rings to not reach the "noise floor" as would be predicted if all contrast in the image arose from phase contrast attenuated by a spatial-coherence envelope. Computationally, the authors show that this "Thon ring floor" is raised under conditions where more of the recorded image power consists of SSB signal (increased defocus or small field of view)<br /> - theory predicts that, at the fluencies normally used in cryoEM, the spatial coherence of the illumination supplied by modern eletron sources is such that one would not expect significant defocus-dependent attenuation effects<br /> - most compelling, the relative intensity of Thon rings in actual images is well predicted by the fraction of image features for which signal for both side bands is recorded (Fig 4)

      My only significant reservation with this manuscript is about the "messaging", and specifically this sentence of the abstract: "The principal conclusion is that much higher values of defocus can be used than is currently thought to be possible". <br /> While the authors have convinced me that the negative effects of defocus were misunderstood and overstated, their claim that higher defocus could be used with no ill effect should be qualified (preferably in the abstract, and in the main text) to make it clear that they are only referring to the imaging part of the experiment, and not the image processing part of experiments, where high defocus values would force users of most packages to use very large box sizes at various parts of the process creating unusually large computational burdens, and/or other problems may occur. If the authors want to keep the claim as is, they should add experimental results that support it, e.g. high-resolution apoferritin reconstructions obtained from both low and high defocus datasets, along with characterization of the mean SSNR, ResLog plot, or similar, in each case. Probably better to keep the paper more or less as is and just qualify this claim, in my opinion.

      Beyond that, I have more minor suggestions / questions.

      (1) Abstract: I'd encourage the authors to consider removing the sentence remove about correcting mag distortion ("We also show (...) many orientation") - if I understood correctly, this becomes very significantly only at very large defocus, and only if averaging spectra to 1D curve before fitting. For these reasons, I think this is a rather minor point of the paper. In the context of the abstract, I think this aside distracts from the main message

      (2) Abstract: "and Ewald sphere correction". Perhaps I missed it, but I don't recall reading in the main text an explanation of why defocus should allow for better Ewald sphere correction, or a demonstration that this is the case. I suggest removing this from the abstract, or adding text explaining this, or a citation to a reference that does (on that note, after a quick re-read of Russo & Henderson 2018, I also don't see an obvious demonstration there that higher defocus yields better Ewald sphere curvature correction, but I'd happily stand corrected).

      (3) Page 3: "This is because compensating information, which unfortunately is of no use, may enter the image from features that are outside the field of view." On first read, this sentence confused me - I think because the phrase "compensating information" threw me off. How about something like "This is because unrelated single-side-band signal delocalized from features outside the field of view may enter the image."?

      (4) Page 4: "Since delocalized (...) high defocus values to record images (Russo and Henderson 2018b)". I think readers who like me are not well versed in the optics and maths of SSB imaging, this statement is difficult to understand. Could it be explained a little further / clarified? To spell out my confusion: why does the feasibility of recovering SSB information even the absence of the Friedel mate mean that it should be advantageous to operate at higher defocus?

      (5) Same paragraph ("We note that information in (...) become greatly reduced"). This whole paragraph argues (I think) that collecting highly-defocus images is OK, yet wasn't one of the points of Downing & Glaeser (2008), cited in this paragraph, that the larger the defocus the lower the more CTF correction schemes or Wiener filters fail at retrieving all of the information (due to the "twin image" problem). My apologies If I'm mis-understanding - if that's the case perhaps other readers will also need a bit more hand-holding through this paragraph.

      I loved all the detail poured into M&M, so I suggest specifying further:<br /> (6) Page 5: "annular zones of 1 reciprocal-space pixel" - how was interpolation done here? Nearest neighbor?<br /> (7) Page 5: "floated" - I assume this means adding a constant so that the average value is zero?<br /> (8) Page 6: "Smooth curve" - fix capitalization. Also, what kind of smooth curve?

      Results:<br /> (9) Page 6: "The integrated power at 2.35 Å" - measured how? In real space in the white box?<br /> (10) Page 6: "(67% of intensity)" - 67% of which intensity?<br /> (11) Page 6: "~0.23 nm" - to guide the eye, please add a second x axis in figure 2, or replace the existing one, so that we can look for the 0.23 nm feature.

      (12) Page 7: "The mean value of this noise spectrum can be regarded as the "zero baseline" for the power spectra of images recorded with a specimen". This noise floor will rise as a function of the number of electrons incident upon the detector. The choice of illumination condition when collecting "no-object"/"beam-only" images for these experiments is therefore important. I assume that the authors used the same illumination conditions as had been used in the actual experiment with a specimen. Is this correct? Either way, could the authors briefly mention somewhere what illumination conditions were used for this? <br /> -- I expect that using the same illumination condition would lead to an overestimate of the height of the noise floor. Indeed, during experiments with specimens, some fraction of electrons will be lost to apertures, leading to an overall decrease in the average number of eletrons reaching the detector. One may thus expect the actual noise floor in "with-specimen" experiments to be even lower, perhaps making the authors' point even more striking.

      Discussion:<br /> (13) Page 7: "did not prevent images at 8 um defocus from being recoded at a resolution of 1.44 Å". Is this shown somewhere? Fig 1C shows 1.3 um defocus, not 8 um.

      (14) Figure 2a: could the X axis be re-labelled, or also labeled with spatial frequency in nm-1 or Å-1 - this would help locate the 3.5 Å bump mentioned in the discussion

      (15) Suppl Figs 4 and 5: here also, having a second X axis, or a second set of labels with spatial frequencies would be helpful.

      (16) Figures S4 and S5: The lower bound of the Thon rings is "raised" with increased defocus, as predicted by the increase in SSB signal, but why is this lower bound so much higher at around 0.5 Nyquist, while remaining low at the origin and edges of F space? Is this predicted by the model? Does it correspond to the FT of the shape of the circular mask used in generating the simulated images?

      (17) Page 9: "to interference between the contributions (...) which is 2a". This sentence reads as though the two SSB beams are interfering constructively or destructively with each other. Unless I'm mistaken the interference is between the scattered beams and the unscattered beam, is it not? That's certainly what the next sentence seems to say.

      (18) Page 9: "The persistence of lattice images within (...) displaced from the particle". Likely because of my lack of expertise, and specifically because I do not know what the "coherence diameter" is, this sentence was lost on me.

      (19) Page 10: "We note that this behavior is different (...) envelope function". For completeness, how about adding a supplementary plot overlaying the observed behavior (as in Fig 4) and the prediction from the spatial coherence (at whatever beam characteristics best fit the data, to point out perhaps that an unrealistic illumination semi-angle would be needed to fit the data)? This would help readers like myself who are not quite certain what one would expect such plots to look like if spatial coherence were really at play here.

      (20) On the subject of Figure 4, I am curious about why the last few points of the 2.3 Å series seem so far off the prediction. The authors made a point of saying that the power spectra were so oversampled that even at that frequency, they had 3 pixels sampling each ring. So why the discrepancy, if not undersampling/aliasing? This made me curious: what would an equivalent plot from the simulation data look like? Would the Thon ring amplitudes from this synthetic experiment be a closer match to the predictions (dashed lines in Figure 4)? If not, perhaps this mismatch is due to poor sampling of these very fine rings at high defocus after all?

      Summary and conclusions<br /> (21) Here might be a good place to formulate some caveat about the practicalities of processing data collected at very large defocus.

      Figures & supplements<br /> (22) Figure S5: this would seem to argue strongly against evaluating the power spectrum using patches - would the authors agree? if so, how about mentioning it in passing somewhere? The optimal way to compute power spectra for the purpose of CTF parameter fitting is still a topic being discussed in the literature of late, and this observation would seem to be relevant.

    1. On 2019-11-03 10:40:59, user Jubin Rodriguez wrote:

      Very interesting study! I was curious to know from the personal experience of the authors if GRiD exhibits better accuracy than iRep with regards to estimation of replication rates (of course I understand from reading your paper that both methods apparently do not fare that great with slowly growing bacteria!)? The reason I ask is cos' I'm getting a lot inconsistent replication rate values between iRep and GRiD for the same MAGs. For example I have a MAG (75.1% completeness and zero contamination & strain heterogeneity; 12X coverage) for which iRep estimates the replication index value to be 1.95 while GRiD outputs a value of 1.24. My gut feeling is that the GRiD estimated value is more closer to reality here but there's no way for me to be absolutely sure here since I've not made any real-lab measurements like you've done for your study. I was hoping to know if you would have any sort of inputs here to share from your own experiences?

    1. On 2021-05-27 17:09:25, user Allan Konopka wrote:

      I found this work via Antonia Fernandez-Garcia’s blog post from summer 2020, and thought it very intriguing. As I have a deep interest in physiological microbial ecology, I have wondered for some time now “whither metagenomics?” and this approach that categorizes GC’s by their “knownness” is helpful. Muren asked me to make further comment on a tweet (https://twitter.com/Hamatsa... "https://twitter.com/Hamatsa50/status/1397586142178865154?s=20)") <br /> here, to hopefully start a conversation.

      So first, what is the objective of applying metagenomics? Sometimes stated (at least in grant proposals) is to “develop a predictive understanding of microbial communities.” But this implies knowing the function of the relevant gene products in adequate specificity (i.e., what specific biochemical function they carry out). We could all come up with lists of important functions, but let me identify 3 which I think are particularly problematic re: the databases of information.

      1. Premise: the instantaneous activity rates of microbes are limited by the fluxes of an essential resource (for chemoheterotrophic bacteria, this is most often the diversity and concentrations of organic energy substrates)<br /> Inference: the breadth, levels of expression, and biochemical affinities of specific transport proteins are critical to understand interspecific competition in natural habitats.<br /> Problem: inadequate specificity – if “known” as (for example) an ABC transporter, this isn’t helpful in predicting in which cases a microbe has a selective advantage. [please correct me if there is recent work that improves this issue]

      2. Premise: microbes/microbial communities rarely (if at all) exist in steady-state conditions. Rather, there are both regular and stochastic environmental perturbations to which organisms may evolve different strategies in response. [Side note: my fav paper on this is Nature’s Pulsing Paradigm, Estuaries 18: 547-555 (1995) by the three Odum brothers. Although about estuaries, easy to think how it applies to other systems and down to microscale.]<br /> Inference: Genes for regulation will be key here. <br /> Problem: I haven’t found much metagenomics work that addresses these regulatory proteins [please correct if necessary, as I have not done an exhaustive search of literature]. Likely (?) similar problem to transporters – motifs identifiable, but specificity of binding site unknown.<br /> Although most genome-scale simulation models (generally of one organism) generate a steady-state solution (and hence less useful ecologically), one can apply heuristics to simulate what you think you know re regulation (but this is outside metagenomics itself)

      3. Premise: The extreme end of the “Pulsing Paradigm” are microbes in highly spatially structured habitats (soils, deep sediments, etc) in which the resource pulses are temporally rare<br /> Inference: evolutionary strategies that favor low/very low rates of metabolism (dormancy) better than the “optimistic” one high macromolecular content in terms of maintaining viability until the next pulse<br /> Problem: relatively weak understanding by microbial physiologists of dormancy (going beyond endospores)

    1. On 2019-03-14 01:10:12, user Charles Warden wrote:

      I noticed that the earlier EDGE paper wasn't cited in this pre-print (or listed in the "software" section of the Storey website):

      https://academic.oup.com/bi...

      Perhaps this citation should be added?

      I thought the "ODP in EDGE (Storey et al. 2005)" plot in Figure 2 of the previous EDGE publication reminded me of the mODP plots in Figure 3 this pre-print. It looks like the "UW Biostatistics Working Paper Series" citation in the previous EDGE paper later became the peer-reviewed citation [3] in this pre-print (and I'm sure you understand everything better than I do). However, I thought the main result that caught my eye was Figure 2 in the earlier EDGE paper, so I thought I should say something.

      I hope everything is going great with you!

    1. On 2021-01-11 12:03:54, user YC Foo wrote:

      Hello! Many thanks for making this available here! May I know if it would be possible to gain access to the Supplemental Tables mentioned here in the article, specifically Sup. Table 2? I'm afraid I've not been able to locate them from the text. Many thanks!

    1. On 2024-11-30 19:30:43, user avtrader wrote:

      BioRxiv Violation

      The author claims no competing interests, yet he and others have said he is the Science Director for Mission Ivorybill. Mission Ivorybill's stated goal--is to save the Ivory-billed Woodpecker. Mission Ivorybill or the related, The Louisiana Wilds do not seem to be federal non-profits via a 501-c3 data base search.

      Mission Ivorybill raises money via various channels and seems to be a commercial entity; this violates BioRxiv's publication rules for authors in addition to being a non-disclosed conflict by the author. Mission Ivorybill also has Go Fund Me efforts, publications, etc. and the organization is IBWO-centric. The author participates vigorously in marketing Mission Ivorybill. He controls and/or participates in Mission Ivorybill's media and marketing efforts such as their Facebook page and Zoom public presentations. The author reviews evidence gathered by Mission Ivorybill yet fails to disclose the relationship tainting this prepaper's Abstract and Conclusions.

      Mission Ivorybill is mentioned in the subject paper. The author is well known to exaggerate claims of Ivory-bills recently proselytizing a video of a Tufted Titmouse was an Ivory-billed Woodpecker is association with a Mission Ivorybill presentation and on social media. The founder of Mission Ivorybill quickly distanced himself from the false Ivory-billed claims by the author.

      The author receives organizational support, professional and informal introductions, recognition, publicity and public face-time from Mission Ivorybill/The Louisiana Wilds perhaps in return for his often aggressive marketing efforts for Mission Ivorybill. His efforts have even included researching and contacting employers, to disparge and econimically damage people who disagree with him on the Ivory-bill's status.

      The author may have purposely not disclosed this unambiguous conflict and his association with a possible commercial entity whose only product is the Ivory-billed Woodpecker. Related the subject BioRxiv prepaper has some hyperbolic, marketing-like claims that are not based in science.

    1. On 2018-02-23 14:06:51, user Mikkel C. Vinding wrote:

      Interesting finding. Surprising how lousy scientist is at keeping time. I will be sending links to this next time I have to arrange a conference. With this amount of people going over time, it is hard to blame the individual, conference organizers have to step up to their job.

      To improve the paper, I would suggest that you report how you constructed the regression model that you use. For example, what are the fixed effects and what are the random effects (are there any random effects? There ought to be in this design), and what precise are the predictors in the model? It would also be nice to know what software you used for statistical tests. Perhaps due to not knowing how the regression was done, I have a hard time interpreting the p-values: Are they the result of an ANOVA or are they the p-values of the regression coefficients (beta)? In the latter case, it might be considered controversial to base conclusions upon the p-values (see https://stats.stackexchange... "https://stats.stackexchange.com/questions/185360/t-value-associated-with-nlme-lme4)"). Finally, it would be interesting to see whether there is an interaction between gender and career step - to see if the stereotype that old male professors just don't give a damn about anything holds up.

      Keep up the good work.

    1. On 2019-02-19 08:48:44, user Mike Fainzilber wrote:

      The authors state in the introduction that "Successful generation of a long 3´ UTR knockout mouse using CRISPRCas9 in mice has not been yet been reported". I beg to differ. Apart from the Xu et al BDNF long UTR model cited in the manuscript, the following models have been generated and published with in vivo phenotypes and mechanistic explanations

      Miller et al, Neuron, 2002: Targeted mutagenesis of CaMKIIalpha 3'UTR shows LTP and memory phenotypes due to loss of the protein in dendrites - https://www.ncbi.nlm.nih.go...

      Perry et al, Neuron, 2012 and Cell Reports, 2016: A floxed allele of the long 3'UTR of importin beta1 was generated. Cre mediated excision of this allele removes the protein from sensory axons, with effects on regeneration (the 2012 paper - https://www.ncbi.nlm.nih.go... ) and on axon growth rates (Perry et al., Cell Reports, 2016, https://www.ncbi.nlm.nih.go... ).

      Terenzio et al., Science, 2018: Crispr/Cas9 mediated deletion of mTOR 3'UTR has in vivo consequences for general local translation in axons, and for neuronal survival after nerve injury - https://www.ncbi.nlm.nih.go...

    1. On 2020-09-04 12:42:15, user Sadegh Nabavi wrote:

      The findings in this paper go well beyond learned fear responses. I wouldn't be surprised if similar changes in responses are observed in other defensive behaviors. It would be interesting to test Nlgn3-/y line in innate defensive behaviors. It is known that dPAG controls escape response to a looming stimulus.

    1. On 2025-06-16 05:52:19, user Jack Durant wrote:

      Potential bias for gram-negative bacteria introduced in the DNA isolation or amplification methods? There are several reports of the isolation of Gram-positive bacteria from the symbiotic cavities.

    1. On 2016-07-27 10:33:29, user Vladimir Seplyarskiy wrote:

      Dear Iain and David,

      I am really like your very well-timed article.<br /> I would like to point out that different numbers of mutation on transcribed and non-transcribed strands may be interpreted in a slightly different manner.

      Methylated cytosines in CpG context after deamination converted to thymine and thus do not cause polymerase stalling and cannot be detected by TC-NER. Moreover, nucleotide and trinucleotide composition vary between strands, therefore even the same mutation rate on transcribed and non-transcribed strands causing the different number of mutations.

      Also, transcription-dependent asymmetry may be a consequence of different mutation forces on different strands, but not solely repair.

      Good luck in journal.

      With best regards,<br /> Vladimir Seplyarskiy

    1. On 2023-07-19 12:56:20, user Pat Schloss wrote:

      A reader pointed out a small, but significant typo in the first version of this preprint. The sentence, "They then randomly select that many sequences, with replacement from each sample", should have "without" rather than "with". Thus the sentence would read "They then randomly select that many sequences, without replacement from each sample". This correction will be included in the next version of the preprint

    1. On 2017-01-21 22:01:05, user German Dziebel wrote:

      Suppl Fig S9 is interesting. The authors state that "Using the Y chr sequence of a ~49,000-year-old Neanderthal from El Sidron Spain (Mendez et al., 2016), we found indeed closer genetic distance to this Neanderthal for haplotype A0, A1a, B, E, D and C, in the order of low to high distance which happens to correlate with degree of African ancestry, relative to G and HIJK (Supplementary Figure S9). These results indicate that admixture of F AMH with Neanderthals may have resulted in African-like descendants with ABCDE megahaplotype who largely preferred to live in the Southern hemisphere." What stands out to me on this figure is the fact that A0, A1a and B are closer to the Neanderthal sequence than C,D, G and HIJK. Could the most divergent human Y-DNA sequences have introgressed from Neanderthals? At the same time, hg E, which is most frequent in Africa doesn't seem to be closer to the Neanderthal sequence than non-African C and D.

    1. On 2024-03-17 07:37:14, user Hiroshi Mori wrote:

      In order to properly use this tool, users must purchase a KEGG FTP license. In the config.yml file of this tool, the following description exist. "KEGG_FTP_DATA_DIR: '/scratch/shared_data_new/KEGG_FTP/2023-10-11/kegg' # Replace with your KEGG FTP data directory".<br /> Authors should mention this restriction (i.e. KEGG FTP license required) in the manuscript.

    1. On 2019-07-24 15:23:44, user Miguel Valvano wrote:

      Very interesting manuscript. I would like to make the suggestion that the clusters called "cps" be separated between O antigen (genes located between GalF and gnd) and cps [proper] genes located opposite from GalF. I am not sure for Klebsiella, but I know the is valid for Escherichia, Salmonella, Shilgella, Enterobacter and many others. You cannot properly call cps (as defined in this paper) as group 1 and group 4 capsules.

    1. On 2017-04-07 21:26:19, user Eran Halperin wrote:

      In more details, we found several major fundamental statistical flaws in the analysis in this manuscript. This manuscript posits six main criticisms of the claims made in our earlier response letter that discusses advantages of the ReFACTor method (Rahmani et al., Nature Methods, 2017). This manuscript misses several crucial parts of our letter, most of which are in our paper’s supplementary file (http://www.nature.com/nmeth... "http://www.nature.com/nmeth/journal/v14/n3/extref/nmeth.4190-S1.pdf)"). The above is true both for their recent correspondence as well as this manuscript. We outline a few examples of these flaws below:

      1. The first section of this manuscript incorrectly states that ReFACTor breaks down when applied to cancer tissue in an EWAS setting. They argue that the permutation test we performed in our analysis (Rahmani et al., Nature Methods, 2017) is not valid. However in our permutation analysis, we constructed the list of “true positives” based on the exact same criterion used by Zheng et al. in their correspondence (Zheng et al., Nature Methods, 2017). In particular, we required differences in methylation between the two “controls” and the remaining methylation levels to have over 50% difference in mean methylation. Most importantly, we instructed users in the original ReFACTor paper, in our response letter to Zheng et al., and in the software associated with ReFACTor, to apply the feature selection step of the ReFACTor algorithm on the controls when the number of true positives is expected to be large. However, this manuscript ignores these instructions as well as many of the other details we provided about the breast cancer analysis (Supplementary Note 1 and Supplementary Note 2 in Rahmani et al, Nature Methods, 2017).

      2. The second section of this manuscript tries to respond to our claim about the inapplicability of the method RMT (Teschendorff et al., 2011) for determining the dimension of ReFACTor. However, the section does not acknowledge our key point; RMT can not determine how many signal components capture the cell composition variation in data. Moreover, as we demonstrated in our recent correspondence (Rahmani et al., Nature Methods, 2017), comparing the performance of the two methods using small datasets cannot provide significant evidence for the improvement of one method over the other. The remainder of issues raised in this section were already addressed in Supplementary Note 3 of our paper.

      3. In the third section, Zheng et al.’s manuscript does not accurately reflect our experiment’s protocol. In our experiment, we divided the samples into two groups on the basis of their cell-composition. Our experiment did not change the methylation levels to any degree. Therefore, we did not consider a scenario for which ReFACTor was designed, as claimed by Zheng et al. We merely assigned a "case" or a "control" label to each sample. Assignment of a label was based on the individual's estimated cell composition. Since the methylation data were not changed, the ReFACTor components calculated for each dataset are precisely the same ReFACTor components one would use in a real study. The batch effects noted by Zheng et al. would only have effects on EWAS results when they are correlated with the phenotype. In our case, the phenotype (case/control status) was generated only on the basis of estimating the cell type composition. Therefore, batch effects could be introduced only if the reference-based method captures batch effects. For more details, please see Supplementary Note 3 of our response letter (Rahmani et al, Nature Methods, 2017).

      4. The relatively low R^2 values in the GALA data are due to a time lag (four months) between procurement of blood samples for measuring methylation and procurement of samples for measuring cell counts. While not ideal, this time lag will not affect the comparison between methods, as the noise added due to the time lag affects all methods equally. Moreover, at the time of publication, there was no other public dataset that had both cell counts and methylation data of this scale.

      5. In the fifth section, Zheng et al do not accurately reflect the assessment of performance we presented in our paper. For example, the Rheumatoid Arthritis EWAS in the original ReFACTor paper (Rahmani et al. 2016) was not designed to show that ReFACTor outperforms the reference-based approach. In contrast, in our recent manuscript (Rahmani et al., Nature Methods, 2017), we provide strong evidence that ReFACTor has better performance over the reference-based methods (see Supplementary Note 3).

      6. The sixth section of this manuscript contains several problematic assertions and unjustified claims. In the original ReFACTor paper (Rahmani et al. 2016), we compared ReFACTor with all the reference-free methods that we were aware of by the time of writing the paper. We chose reference-free methods that correct for cell type composition in methylation; we also considered a few methods from the gene expression literature (e.g., PEER). We find surprising the accusation that we did not compare ReFACTor with RUV. The authors of this manuscript (Zheng et al.) have published other papers in which they did not compare their suggested methods with RUV (e.g., Houseman et al. 2014, Houseman et al. 2016, Koestler et a. 2016, Teschendorff et al. 2017). We do not argue that comparison to RUV or to other methods is not useful, however the claims made by the authors of Zheng et al. are double standard. Finally, the McGregor et al. analysis did find SVA to be more stable in comparison to the alternatives in some scenarios, however, this study did not consider ReFACTor in their benchmarking, as their study was conducted while the ReFACTor paper was under review.

    1. On 2020-09-18 02:09:42, user Maria Ingaramo wrote:

      Summary: for now, we recommend using the S11 tag at the N-terminus of target proteins.

      Details:<br /> We'd like to thank Dr. Abby Dernburg for pointing out that our S11 fragment, which ends in two glycines, might act as a C-terminal degron signal (doi.org/10.1016/j.cell.2018... "doi.org/10.1016/j.cell.2018.04.028)"). We've successfully tagged proteins at both the N-terminus and the C-terminus, but we have not established that these yield similar expression levels. We take this concern very seriously, and we're checking this now. Results will be posted here and at andrewgyork.github.io/split_wrmscarlet. In the meantime, we recommend avoiding the potential issue by attaching the S11 fragment at the N-terminus. If C-terminus tagging is required, we suggest the alternative S11 sequence YTVVEQYEKSVARHCTGGMDELYK.

      -Maria Ingaramo

    1. On 2019-01-27 11:18:19, user Interested_party wrote:

      Excellent paper; very useful. Could you provide information as to how the FnCpf1 PS were cloned into the vectors? Looks like you using a TGAG overhang, did you modify pCRISPomyces 2 to remove the gRNA scaffold? Also, will you be making these vectors available?

    1. On 2022-10-23 03:07:17, user Wenwu Wu wrote:

      An interesting study. Genes associated with cuticular wax and flavonoid biosynthetic pathways are highly expressed in leafy bracts, likely shedding lights. I wonder whether these genes are among the convergent natural selected genes in the species.

    1. On 2020-02-14 19:29:28, user Greg Gomes wrote:

      Hi Guest,

      One of the authors here. This is precisely the type of feedback/discussion that BioRxiv is great for! Thanks!

      The smFRET distances in Piana et al., are inferred from smFRET transfer efficiencies using an assumed homopolymer model. In our manuscript (and others) we show that deciding which, if any, homopolymer model is appropriate for a particular IDP is difficult, and allows considerable flexibility in the inferred distances. Our results compare smFRET effeciencies directly rather than using derived values from the data via polymer theory assumptions.

      That being said, I take the point that phrases such as "novel", "new", and "for the first time" could be (or are) claims of priority, which are difficult or impossible to assess - and should therefore be avoided. The updated version will cite the referenced paper, as it is work that should be acknowledged.

    1. On 2016-01-14 13:55:48, user Natalie Davidson wrote:

      In the Methods section "Model for the fraction of sampling and fragmentation duplicates", I am guessing that this explains the method for calculating the expected fraction of duplicates with sampling only (in red on figure 3b), how do you calculate it for sampling+fragmentation (in blue on figure 3b)?

    1. On 2020-12-30 19:11:26, user Jon Moulton wrote:

      This is the first clear exploration of the upper thermal limit of zebrafish culture that I have seen. At 37C the zebrafish-parasite system can be a useful model for human parasitic disease (doi:10.1111/jfd.12393); now we know how close to the temperature limit that culture system really is.

    1. On 2018-11-30 11:52:13, user Mubassherul wrote:

      You did a nice work which makes NER faster. I really appreciate it. All the recognized name are disambiguated by identifiers which sources are from different databases. I am pretty curious that sometime "Acronyms are often homonyms".So, how the tagger manage this problem? It would be great if the user can get return of the results instead of returning the result to central BeCalm server. Great job. Thumbs up.

    1. On 2021-02-23 15:13:18, user Jon Fisher wrote:

      This is an interesting analysis, but I see two aspects that would make it hard for it to get traction. First, as noted in the abstract, poor enforcement is a major problem now, and rapidly expanding PAs into areas suitable for agriculture would make enforcement much harder (even if more resources were available). Second, it appears that this centers around the need of species to keep almost all of their range, but doesn't seem to consider the needs of people to grow enough food and have livelihoods. Starting solely with an ecosystem need without considering capacity for enforcement nor opportunity cost to human well-being makes this pretty non-convincing to anyone who isn't already strongly supportive of conservation as a top priority.

    1. On 2019-07-11 17:42:25, user Vagner Benedito wrote:

      Very nice work, folks!<br /> I'd like to offer a few remarks to improve the manuscript:<br /> It would be good though to describe which leaves exactly were used for extraction, how much plant material per unit of solvent was used in the leaf dipping (and confirm that the exuding trichomes were preserved after the dipping - so that you captured RNA from these structures in the analysis - I'd fear that most trichomes would break from the leaves during the ethanolic dipping).<br /> An additional supplemental table with locus ID correlations between Sopen and Solyc orthologs would be very helpful.<br /> In your model (Fig 8), I'd add an element for the import of metabolites from the subapical cell, since it is very possible that the apical glandular cells is not fully responsible for generating substrates for acylsugar biosynthesis!<br /> I really like the way this paper used a simple comparative RNA-Seq approach to identify novel candidate genes involved in acylsugar metabolism - great job!

    1. On 2022-10-31 15:51:23, user Daniel Lüdke wrote:

      We appreciate the schematic diagram of light conditions/treatments in Figure 5. Would it be possible to include similar diagrams for the other figures as this would make it easier to follow how plants have been treated. In the methods could it be described in more detail at what point after infection the light conditions were applied?

    1. On 2024-12-27 03:11:02, user samuel Yi wrote:

      Thank you very much for this remarkable work. While reading the article, I noticed a detail that warrants further discussion. The authors used Codex staining results from adjacent sections as the gold standard to evaluate the performance of different spatial omics technologies. However, Codex exhibited relatively strong edge staining effects in certain channels, such as CD20, which led to an abnormal accumulation of B cells at the periphery of the sections. This observation is inconsistent with the results obtained from hematoxylin and eosin (H&E) staining. Therefore, a more meticulous examination of the Codex data analysis may be necessary to address these discrepancies.

    1. On 2019-10-17 15:43:29, user Adrienne wrote:

      Really amazing resource! I have also found the T cell isolation bead kits (by negative selection) result in CD8 loss - probably due to NK receptors expressed on CD8 populations. CD8+ MAIT cells are particularly reduced following bead-based T cell isolation - this can inform what the composition of antibodies may be (which StemCell won't disclose).

    1. On 2016-08-31 23:02:23, user Mike Gandal wrote:

      Really interesting method. Very glad to see that you are correcting for variability in GC content and looks like 5'/3' bias is in the works. We find that technical factors related to RNA-sequencing (library preparation, read depth, 3' bias) contributes substantially to RNAseq expression variation and is poorly accounted for by current methods.

      I liked your comparison to other methods using GEUVADIS and SEQC datasets. It would be helpful to see how a few other "standard" methods perform: tophat2 alignment with cufflinks quantification or STAR alignment and HTseq-counts quantification.

      Also, most of the standard quality control packages for RNAseq data work at the .BAM/.SAM level (e.g., PicardTools or RSeqQC). It would be interesting/helpful for fast transcript abundance estimator methods like this to be able to interface with such quality control pipelines.

    1. On 2021-09-05 15:00:48, user UAB BPJC wrote:

      Review of Barrasso et al., “Impact of a human gut microbe on Vibrio cholerae host colonization through biofilm enhancement” by the University of Alabama at Birmingham Bacterial Pathogenesis and Physiology Journal Club

      Summary

      This lab previously showed that Paracoccus aminovorans could be found in higher abundance in Vibrio cholerae-infected individuals compared to non-infected individuals. This study demonstrates that V. cholerae colonization is increased by the presence of P. aminovorans in an infant murine intestinal model of infection. Through crystal violet staining and murine intestinal colonization with a ?vpsL mutant of V. cholerae, it is shown that Vibrio exopolysaccharide (VPS) is necessary for P. aminovorans-dependent enhancement of V. cholerae biofilm formation and intestinal colonization. Microscopy also reveals VPS enrichment in areas of the pellicle with higher P. aminovorans abundance. Lastly, with mutants in accessary matrix proteins RbmA, RbmC, and Bap1, the researchers show that the ability of V. cholerae to form a structurally intact biofilm is necessary for P. aminovorans-dependent enhancement of V. cholerae colonization.

      Overall, this is a very interesting paper with insightful experiments that sparked a great discussion in our journal club group. This paper gives strong evidence that P. aminovorans promotes V. cholerae colonization in a VPS-dependent manner. With that said, we have some comments that may be beneficial for the authors to address.

      General comments<br /> * May be beneficial to keep y-axis scales for CFUs the same among all figures for more consistency<br /> * One-way ANOVA may be a more appropriate test for figures in which multiple comparisons are being made; we advise you to consider consulting a statistician on the appropriate statistical tests to use<br /> * The Mann Whitney U test is not a t-test, but is referred to as such in some of the figure legends. <br /> * It is mentioned multiple times that crystal violet absorbance was measured at 570nm, although measurements were made at 550nm for all crystal violet figures in the paper. <br /> * Discuss possible limitations with Wheat Germ Agglutinin; could WGA also stain GlcNAc produced by P. aminovorans?<br /> * Would be beneficial to describe in more detail the purposes of matrix proteins RbmA, RbmC, and Bap1, and why these were chosen to be studied.<br /> * One statistical test is mentioned at the end of every figure legend; is the same statistical test being formed on all panels in a given figure? If not, this needs to be clarified.<br /> * More details about how CFUs are quantified from pellicles in the results section would be good to add; the steps taken are only briefly mentioned and are a bit difficult to understand.

      Figure-specific comments<br /> * Story may flow better if in vivo data from Figure 2 is added to the end of the paper along with Figure 7 in vivo data; introduce enhanced Vc colonization phenotype with in vitro data first<br /> * Would be beneficial to show single and dual species P. aminovorans CFUs in Figure 2B and 2C and also single species P. aminovorans CFUs in Figure 3B to see whether P. aminovorans colonization also increases in the presence of V. cholerae <br /> * Address the purpose of the grid in Figure 4A<br /> * Figure 5A: Title claims that P. aminovorans increases V. cholerae biofilm formation according to data in Figure 5, but can only make this claim if CFUs are quantified in the in vitro model.<br /> * Figure 6 should have a Vc single species control to compare dual species pellicle to.

    1. On 2024-04-30 20:15:37, user Austin McIlhany wrote:

      Fascinating paper both on the topics of cutting edge field of microbiomes and still-ongoing issues of human-caused environmental crises, specifically oil spillages. Here are a few ideas and questions I have that I think could possibly improve this paper:<br /> 1. Since this study focuses on N and P levels and hydrocarbon degradation, then the levels of N and P in the collected seawater need to be quantified.<br /> 2. I understand that it must not be under lab-ready circumstances to extract AND analyze the samples of the artic waters at the same exact location for a more accurate sampling of the microbiome<br /> 3. The levels in the three growth conditions of high, low, and ambient. It would be helpful to list all ingredients and their final concentrations for the three conditions as well.<br /> 4. Perhaps in the future, the use of transposons could also be used to track the genes that correlate with biodegradation of crude oil, and which strains/taxa of bacteria they originate. Making a isolated, pairwise and community could also help narrow it down.<br /> 5. PCR conditions for the V4 amplification should be described.<br /> 6. In the “differential abundance analysis,” were there adjustments made for different 16S copy numbers in different taxa? Different genome sizes? If not, this must be mentioned as a limitation.

    1. On 2024-11-21 16:07:10, user Phillip Gienapp wrote:

      This manuscript has now been published as:

      JJC Ramakers, TE Reed, MP Harris & P Gienapp (2023) Probing variation in reaction norms in wild populations: the importance of reliable environmental proxies. Oikos e09592 doi: 10.1111/oik.09592

    1. On 2017-11-07 15:26:42, user guillemaud wrote:

      PREPRINT PEER REVIEWED AND RECOMMENDED by PCI EVOL BIOL

      This preprint by Chauve et al has been peer-reviewed by by Mukul Bansal, Alexandros Stamatakis and 2 anonymous reviewers and recommended by Tatiana Giraud and Toni Gabaldón for Peer Community in Evolutionary Biology. Peer-reviews, decisions, author's replies and the recommendation can be found here: https://evolbiol.peercommun...

    1. On 2019-03-20 15:27:31, user Claudiu Bandea wrote:

      Free-Living Chlamydiae?

      The finding that new chlamydial lineages, identified as metagenome-assembled genomes (MAGs), dominate the microbial communities in sediment cores from a region surrounding Loki’s Castle hydrothermal vent field (1) is a remarkable discovery.

      Based on estimates of genome replication rate using the iRep algorithm (2), and in context of results indicating the absence of putative eukaryotic host cells in the sediments, the authors proposed that their new MAGs are derived from actively dividing chlamydia not associated with eukaryotic hosts. If true, this represents the first examples of ‘free-living chlamydiae’, an extraordinary finding given that all previously studied chlamydial lineages, both pathogenic and environmental, are obligate intracellular organisms (3,4).

      However, the authors’ interpretation of the iRep results and suggestion of actively dividing extracellular chlamydiae might be questionable. A more likely explanation is simply that the chlamydial EBs, the extracellular spore-like cells in the chlamydial life cycle, contain a chlamydial genome at various stages of replication.

      It is highly conceivable that during the differentiation of the intracellular dividing chlamydial cells, the RBs, into EBs, the chlamydial genomes is in process of replicating, which is ‘arrested’ during the differentiation process. Addressing this hypothesis, which is relevant for the entire chlamydial field, is relatively straightforward: perform a MAG-like sequencing experiment and an iRep study on a population of purified EBs from chlamydial lineages that can be grown in culture.

      One additional comment on authors’ interpretation of the results and their proposal of putative free-living chlamydiae. Apparently, the authors failed to consider that the genome size of the new chlamydial MAGs is intermediary between that of environmental chlamydiae and the pathogenic chlamydiae, all of which are obligate intracellular lineages. Given that thousands of intracellular parasitic or symbiotic lineages have a smaller genome/proteome compared to that of their free-living relatives (4), it is very likely that the newly discovered marine sediment chlamydiae followed a similar evolutionary pathway (see also Ref. 5).

      References

      1. Dharamshi J, Tamarit D, Eme L et al. 2019. Marine sediments illuminate Chlamydiae diversity and evolution. bioRxiv: doi: https://doi.org/10.1101/577767 ;

      2. Brown CT, Olm MR, Thomas BC, Banfield JF. 2016. Measurement of bacterial replication rates in microbial communities. Nat Biotechnol. 34(12):1256-1263; https://www.ncbi.nlm.nih.go...

      3. Subtil A, Collingro A, Horn M. 2014.Tracing the primordial Chlamydiae: extinct parasites of plants? Trends Plant Sci. 19(1):36-43; https://www.ncbi.nlm.nih.go...

      4. Taylor-Brown A, Vaughan L, Greub G, Timms P, Polkinghorne A. 2015. Twenty years of research into Chlamydia-like organisms: a revolution in our understanding of the biology and pathogenicity of members of the phylum Chlamydiae. Pathog Dis.;73(1):1-15. https://www.ncbi.nlm.nih.go...

      5. Bandea C. Evolution of giant viruses from larger ancestors. 2018. Comment in bioRxiv on “Virus genomes from deep sea sediments expand the ocean megavirome and support independent origins of viral gigantism”; doi: https://doi.org/10.1101/469... https://www.biorxiv.org/con...

    1. On 2022-05-18 22:14:12, user Davidski wrote:

      Hello authors,

      Unfortunately, there are some serious problems with the geographic concepts in your preprint:

      • your Steppe region includes a large swath of Eastern Europe that is mostly forest and forest steppe. Only about a third or less of this region is actually a steppe (the Pontic-Caspian steppe). Calling this region Eastern Europe would be more useful and in tune with geographic conventions.

      • what you call Eastern Europe is not generally, by itself, known as Eastern Europe, especially since the fall of the Iron Curtain. That is, Czechia, Hungary and Slovakia (often along with Poland) are nowadays more commonly described as East Central Europe.

      • what you call SE Central Europe is actually much of the Balkans, and thus straight up Southeastern Europe.

      Honestly, calling Bulgaria Central Europe, while, at the same time, calling Czechia (inc. Bohemia) Eastern Europe just doesn't look right.

    1. On 2024-12-05 12:22:35, user xPeer wrote:

      Courtesy review from xPeerd.com

      Summary<br /> The study explores the development of human heart assembloids integrated with autologous tissue-resident macrophages to replicate physiological immuno-cardiac interactions. The research emphasizes the importance of this model for understanding heart development and disease. The authors provide a detailed methodology for generating the assembloids, coupled with multi-omic analyses and functional assays, demonstrating the model's capacity to emulate key cardiac and immune processes. However, while the study presents comprehensive data and a novel approach, certain areas require further clarification and detailed statistical analysis to strengthen the findings.

      Major Revisions<br /> 1. Statistical Analysis: The study lacks detailed statistical information to support the presented data. Including p-values, confidence intervals, and statistical tests used for each dataset is crucial for validating the results (e.g., Figures and gene set enrichment plots).

      1. Reproducibility of Methods: While the methods section is comprehensive, it would benefit from additional clarity on specific protocols to ensure reproducibility. Including precise details about reagents, equipment, and any variations in experimental conditions can aid reproducibility (e.g., generation of heart assembloids).

      2. Integration of Findings: The discussion should integrate the findings more thoroughly with existing literature. Highlighting how the study advances the field and addressing possible discrepancies with previous studies will provide a stronger context for the research.

      3. Limitations and Future Work: The discussion needs a more critical examination of the study's limitations, potential biases, and confounding factors. Proposals for future research directions should be specified to guide subsequent investigations.

      Minor Revisions<br /> 1. Typographical and Formatting Errors:<br /> - Page 15, Figure 2 legend: The phrase "?ë ëë ë ëëë" is a clear formatting error that needs correction.<br /> - Verify consistent formatting of subheadings and figure legends throughout the manuscript.

      1. Definition of Terms: Ensure all technical terms, abbreviations, and acronyms are defined upon their first appearance. This will enhance readability for a broader audience.

      2. Reference Formatting: Ensure all references are correctly formatted according to the journal's guidelines. Cross-check for the latest updates in cited references.

      3. AI Content Analysis: Based on language consistency and technical depth, the estimated percentage of AI-generated content seems minimal. No sections explicitly exhibit characteristics typical of AI-generated text.

      Recommendations<br /> 1. Enhancing Data Presentation: Incorporate more statistical data into figures and tables, such as error bars and exact p-values, to reinforce the reliability of the results.

      1. Detailed Protocols: Append a supplementary section with detailed step-by-step protocols for key procedures to facilitate reproducibility by other researchers.

      2. Expanded Abstract: Enrich the abstract with specific quantitative results to provide a clearer snapshot of the study's impact and conclusions.

      3. Broader Impact Discussion: Expand the discussion on the broader implications of the model for disease modeling, drug testing, and therapeutic applications, tying it back to the study's findings.

      This autonomous review aims to provide a comprehensive evaluation of the study, pinpointing critical areas for improvement while acknowledging its scientific contributions.

    1. On 2022-08-29 10:14:15, user David Curtis wrote:

      I just wanted to point out that I performed a similar study, though on a smaller scale with fewer gene-trait combinations:<br /> Exploration of weighting schemes based on allele frequency and annotation for weighted burden association analysis of complex phenotypes.Curtis D. 2022. Gene. 809:146039. https://doi.org/10.1016/j.g...

      I didn't test VARITY but in my analyses REVEL was not an obvious winner and some other predictors performed better on some genes.

    1. On 2018-03-18 09:51:40, user Slumbery wrote:

      The attached map is seriously bad. The article claims that the population split happened north of the Himalayas and emphasizes that it did not happen in India. Then we have the included map (b) that places the splitting south of the Himalayas and in the middle of India. It totally contradicts the text.

      Also the other map (a) already shows the endpoint of the first expansion pretty much inside the mountain range that separates Central Asia and South Asia, instead of Central Asia as the text claims.

    1. On 2021-03-25 04:15:19, user Aalok Varma wrote:

      Our lab presented this preprint at our journal club, and we thought we could start an open discourse about this work. The characterisation of V1 connectivity was quite interesting, and recording from such a diverse set of cell types in the spinal cord and stimulating over so many segments while retaining recording quality is definitely impressive. Here are some questions we have for you:

      1. Have you tried recording fictive swims, either spontaneous or evoked, with optogenetic stimulation of different segments? One would expect that V1 activation should increase swim frequencies (since knockouts reduce speed), but since some of them are Renshaw cells (in limbed animals) producing feedback inhibition, the result could be something else. Moreover, have you tried monitoring a behaviour in response to V1 stimulation? That could address what role these neurons play in motor control more directly and with more spatiotemporal control than knockout models provide.

      2. What is the effect of V1 stimulation on motor neurons, without network blocking, i.e. what happens if you’re recording from motor neurons in current clamp mode, and you stimulate V1s?

      3. One of the striking results is that almost none of rostral stimulations led to IPSCs. Is it possible that the caudal arm of V1s are actually not axons, but rather dendrites that receive input? Perhaps imaging the localisation of pre- and post-synaptic markers, such as PSD-95 and Glyt2, for instance, within the V1 arbour could address this.

      4. In continuation with the previous question, what are the inputs to V1? Are there V1s that function as Renshaw cells and type Ia interneurons even in zebrafish?

      5. Lastly, is there any definitive evidence of the order in which the various cell types get activated on the arrival of a motor command? The model, for instance, directly connects pacemaker neurons to V2a’s. which would excite motor neurons, which would then activate V1s for feedforward inhibition? Are we correct in understanding how the model is set up, and does that match what one would expect from real spinal cords?

      This work is quite interesting and we sincerely look forward to your thoughts.

    1. On 2020-05-13 17:16:47, user FELIPE MARASCHIN wrote:

      I suppose that, in page 8, in line 139, the sentence "the gain-of-function pPIF4:PIF4-FLAG mutant line (PIF4OX; Gangappa and Kumar, 2017)" relates to an overexpression line? In the referenced paper is attributed to Nozue et al., 2007. Nozue however, describes 2 PIF4 OX lines, one with the native promoter, and another with 35S:PIF4-HA. Nozue reports: "In this PIF4 overexpression line, designated PIF4-OX in this paper, PIF4 is driven by its native promoter but is expressed approximately 25-fold higher than in the wild type, presumably owing to the insertion site of the transgene" which was originally developed by Khanna et al., 2004. Otherwise, the PIF4 line it is a complementation line, not a gain-of-function?

    1. On 2022-05-29 22:25:18, user Andres Betancourt-Torres wrote:

      Summary:

      This work investigates the role of nerve growth factor (NGF) during bone repair. Previous work from these authors established that NGF is important for the reinnervation of injured bone tissue. Here, they explore a secondary effect of NGF on mesenchymal cell migration that appears to be mediated by NGF’s low-affinity receptor p75. Using a variety of genetic techniques, the authors demonstrate that NGF promotes stromal cell migration in vitro, and that knockout of p75 in vivo slows bone repair. Further, p75 appears to control the expression of genes associated with cell migration. Thus, in addition to its role in bone reinnervation, NGF may act via p75 to promote stromal cell migration during bone repair.

      Major successes:

      The major success of the paper is a clear and well established connection between p75-NGF signaling and an effect on mesenchymal cell migration in mice. Also established is the importance of p75 for other processes, such as NGF production in macrophages and ossification of stromal cells.

      Major Weaknesses:

      The authors do not establish whether the effects of p75 knockout are independent of other NGF signaling pathways, such as the Trk family of NGF receptors. Thus, it is difficult to determine the relative importance of p75 versus Trk signaling in many of their experiments.

      Impact: This paper is the first to describe the dependence of calvarial bone repair on p75 signaling. This finding could have important clinical implications for treating bone injuries.

      Major Points:

      -A description of review committees overseeing the use of human samples for the research presented in this paper should be included.

      -Much of the paper relies on understanding the genetic tools, particularly transgenic mouse lines. There is no explanation in the text of what many of these transgenic lines are or what the abbreviations/notation used for them mean (e.g. NgfLysM). Interpretation of the results would be made easier if the authors included one-sentence descriptions of each of these tools and the logic behind using them. The genetics should also be added to the figures when they are critical to the experiment (e.g. a diagram of how the Cre-ER system works in figure 2).

      -In other contexts, p75 plays a modulatory role in neurotrophin signaling through its influence on other receptor pathways (e.g. Trks). The authors did not test here whether the effects of p75 knockout were via independent functional consequences of the p75 pathway, or relied on modulatory influences over other neurotrophin receptor pathways. For example, the results shown in figure 1 could be largely the result of TrkA signaling, with only partial dependence on p75. The additional finding that p75 knockout reduces overall NGF expression by macrophages (Fig 5) also further complicates the interpretation of many of the in vivo results. To address these complications, the authors could test whether p75 deletion from stromal cells influences the function of other neurotrophin receptors. This can be accomplished by using Trk inhibitors in conjunction with the p75 knockout/knockdown (these authors have demonstrated the ability to use such tools in their previous paper). This is an important experiment because it would determine whether the influence of NGF on p75 can be studied independently of its role in promoting reinnervation via Trk signaling, or if the two phenomena are better examined in relation to each other.

      -The authors’ should acknowledge additional caveats of their data from human cells/tissue. An important role for p75 in human cell migration is demonstrated in vitro, but it is not fully established in vivo. The observation that p75 is expressed during human bone injury does not alone indicate its function in vivo. Further, the human samples used were taken from tibia and ribs, whereas the rest of the paper is focused on calvarial bone repair. The authors should address these caveats and adjust the sentence beginning on line 261 to better reflect the full range of possibilities.

      -The paper emphasizes a role for p75 in cell migration. However, it is also clear that p75 likely influences a range of cellular functions beyond cell migration as well. For example, RNA-seq experiments revealed a wide range of genes whose expression changed following p75 knockouts. Functions relating to NGF translation in macrophages were also likely impaired. These findings suggest that p75 may be critical to a broad range of cellular processes during injury repair, rather than just migration. Devoting more text to the discussion of p75’s role beyond just coordinating cell migration may broaden interest in this paper beyond its current scope.

      -The authors should include further details about calvarial defect procedures. Specifically, the authors should elaborate on why they choose this injury model over other available models that could recreate common fractures that skulls experience (e.g. of possible reasons: convenience for observations or less pain for animals). At a minimum, the authors should state a reason why they choose this injury model for their studies. This discussion could best fit in the Materials and Methods.

      Minor Points:

      -The number of observations appears to be underpowered for some experiments. Particularly, the results in Figs. 2K and 4C look to be trending towards significance, but include small sample sizes. A power analysis for these data, or increasing the number of observations per sample for these experiments, would strengthen the authors’ interpretations of the data.

      -The authors state the macrophage populations show a minor shift in population distribution based on the single cell data, but their IF shows significant differences in the number of macrophages at the injury site in the p75fl/fl and p75PDGFRa mice. An explanation for this discrepancy should be included.

      -The data in figure 5 demonstrate that p75 knockout depletes NGF expression in macrophages. This suggests a positive feedback loop between NGF expression and NGF signaling. The authors should explore the consequences of this finding in their discussion as it may be important for considering the interaction between p75 and Trk signaling during bone repair in vivo.

      -The authors should consider testing tissue samples for the presence of osteoclasts, due to the hypothesis that these cells could modulate the activity of osteoblasts. Generating this data would reinforce Figure 2 and the argument that p75 deletion is driving the lack of bone repair.Alternatively, the authors could discuss how osteoclasts modulate the osteoblast activity they describe through the presented data. This topic could be addressed in the Discussion section, for example as either a study limitations or future projections of this project.

      -The authors should consider generating new images for Figure 2 panel I, and see if they can observe osteoblasts in the fracture healing area, using a higher magnification. This could reinforce the comparison among the two conditions presented by demonstrating the presence and hence participation of osteoblasts in the fracture healing process.

      Stylistic Points:

      -The order of the figures is a bit confusing. The authors switch back and forth between in vitro and in vivo experiments. One possible order is: Fig 1, 4, 3, 5, 2, 6.

      -Typo on line 77: “microdissection bone defect site”.

      -Reorganize Figures 1 H and I as Figures 1 B and C; they validate the model, and it may help readers accept the model before reporting any further data.

      -Each chart should have its own legend. Although the color coding is clear, this will help each graph to stand independently from each other and help readers interpret the data quickly.

      -Remove “squares” from the test in the Materials and Method section, or substitute with any possible missing symbol.

      Whitney Tamaki (Whitney.Tamaki@ucsf.edu)<br /> Scott Harris (Scott.Harris@ucsf.edu)<br /> Andrés Betancourt-Torres (Andres.Betancourt-Torres@ucsf.edu)

    1. On 2019-01-17 12:48:50, user Michael Hiller wrote:

      Great to see more well assembled lizard genomes, but it would have been nice to cite the more recent assemblies of Salvator and Lacerta (even if the N50 metrics of both are assemblies better)

    1. On 2022-03-29 09:55:05, user Daniel Baldauf wrote:

      Beautiful study! These are amazingly strong decoding results with 90+ percent accuracy. That's great. I wondered though whether this might have to do with the relatively easy auditory targets (yes/no)?Or is it that the two speech streams can be easily distinguished by low-level features such as the pitch? I would be curious what role you think high-level attentional processes might play in this task, particularly, for example, when it comes to parsing words in a even more noisy environment. For example, recently Marinato & Baldauf (2019, Sci.Rep.) used a speech signal mixed with an environmental 'sound-scene', and showed that top-down object-based attention has a strong effect on the parsing of the language stream. DeVries et al. (2021, JN) then also recorded MEG during such a task, showing that it is particularly the alpha band in a fronto-temporal network that mediates these functions of object-based attention to words, and that allows for successful trial-wise decoding of the locus of attention (but not on quite the same level as 90% accuracy). Best wishes!

    1. On 2023-08-07 14:09:23, user LUCIANO RODRIGO LOPES wrote:

      Dear Professor Porter and colleagues,

      I have read your scientific article with great attention and interest. The initiative to include new species of deer as an experimental model to verify susceptibility to SARS-CoV-2 is of remarkable importance. The susceptibility and virological surveillance analyses involving the white-tailed deer (WTD; Odocoileus virginianus) have demonstrated the potential spillover of SARS-CoV-2 into wildlife. However, this appears to be just the tip of the iceberg. By adopting new species of deer as a susceptibility model, similar to your approach, we can better predict new scenarios involving SARS-CoV-2.

      According to your results, it is concerning to learn about the potential susceptibility of mule deer and their ability to transmit SARS-CoV-2 with real infection capacity, whereas we observed that elk have lower susceptibility to this virus.

      In an analysis involving deer ACE2 protein sequences (https://doi.org/10.1007/s10... "https://doi.org/10.1007/s10393-023-01632-z)"), I compared the binding sites that SARS-CoV-2 uses to enter the host cell. The mule deer shares the same binding sites with the WTD, while the elk has a different site, in addition to the evolutionary distance with the deer of the genus Odocoileus. I argued that this variation in an ACE2 binding site could decrease elk susceptibility to SARS-CoV-2. It appears that our results corroborate each other.

      I conclude my comment here by congratulating you on the interesting work and publication by your group.

      Sincere regards

      Luciano

    1. On 2016-09-01 18:16:03, user Ami Tsuchida wrote:

      Very interesting paper...! I think the main analyses are very sophisticated, but I wonder whether the final analysis truly captures the change in functional connectivity. It seems that the authors simply included the time course of anterior LH as a regressor to compare change in correlation with this seed before and after learning. Isn't it possible that the correlation change because of the patterns of activations change before and after learning (i.e. both anterior LH and PFC regions are recruited during the task at early learning phase, but this pattern changes after learning)? Why not use PPI, modelling both task regressors and the seed time course, as well as an interaction term to see whether the change in correlation is above and beyond the change in the pattern of co-activation? I think the results would be interesting regardless, but the precise interpretation of "functional connectivity" may be different depending on whether it's driven by the change in the responsiveness of these regions to the common task stimuli.

    1. On 2016-01-17 18:40:56, user Anthony Olszewski wrote:

      In this paper my impression is that they are counting bacteria suspended in the fluid of the colon. Are there bacteria on the surface of the large intestine? How many might be there?

      The bacteria concentration in the small intestine contents is stated as 10 to the 3rd compared to the large intestine 10 to the 11th. The surface area of the small intestine is amplified 60 to 120 times. What is the number of bacteria living in this real estate?

      Even if less than originally thought, the surface area of the gut is considerable:<br /> http://www.ncbi.nlm.nih.gov...

    1. On 2025-10-12 06:26:52, user Chenxi Sun wrote:

      Overall, the paper makes a strong and interesting contribution by showing that macrophage mitochondria transferred to cancer cells don’t serve as energy sources but instead act as ROS-producing signals that activate ERK and drive proliferation. I’d rate its significance a 4 out of 5, since this finding changes how we think about mitochondrial transfer, giving it a new signaling role in tumor biology. The experiments are carefully designed — live-cell imaging, RNA-seq, and biosensors all support the conclusions — but most data are from in vitro models, so it’s still unclear how much this process matters in real tumors. The main limitation is the lack of in vivo validation, which would make the story more convincing. Overall, the methods are solid, the logic is clear, and the conclusions mostly follow from the data, even though more physiological testing would strengthen it.

    1. On 2018-05-08 07:52:25, user Mike Fainzilber wrote:

      Very interesting work. The discussion on how precisely MAPK-15 influences length might also consider the possibility that it is part of a motor-dependent length-sensing mechanism similar to that described by us for mammalian neurons (admittedly axon-centric in our case, but nobody's perfect...). See https://www.ncbi.nlm.nih.go... and https://www.ncbi.nlm.nih.go.... There is also earlier work from the Eickholt group on myosin and PTEN in control of somatodendritic compartment size in mammalian neurons that is likely highly relevant, see https://www.ncbi.nlm.nih.go....

    1. On 2020-03-04 10:28:04, user Nikol Reslová wrote:

      Hello, I would like to ask, the database is not working for some time now, will it be available once again or did you close the websites for good? Thanks for your response in advance, NR.

    1. On 2023-06-04 22:27:01, user Dr Ros Jones wrote:

      Thanks for this detailed study. You mentioned concerns about spike protein from infection and from vaccines. Do you have any way to distinguish which you are finding? Were the findings similar in postmortems of those dying post-infection who had also been vaccinated?

    1. On 2018-02-09 23:24:19, user John wrote:

      Forgive me - I only skimmed the paper, so this question may be answered therein. Is one able to compare the scikit-ribo translation efficiency estimates across conditions? (i.e. does the TE for a given transcript differ between conditions A and B?) Or can you only compare the TEs within a single condition? (i.e. does X have a higher TE than Y?)

    1. On 2020-03-23 23:29:20, user Anna Maria Niewiadomska wrote:

      Regarding ORF10:CUL2. Interesting particularly since there's evidence of other coronaviruses interacting with proteins in the ubiquitination pathway. However, two groups performing direct sequencing of SARS-CoV-2 mRNA have not been able to detect ORF10 transcripts and no ORF10 homologues exist in other coronaviridae. Although you do mention there's no evidence for ORF10 expression in the supplementary material, you may want to consider that the ORF10 results may be an artifact of over-expression and mention in the main text.

    1. On 2021-01-22 17:50:16, user Fraser Lab wrote:

      This work reports two atomic models of the main protease (Mpro) from SARS-CoV-2 using serial femto-second crystallography (SFX). The goal of the paper was to use this structural information to assist drug repurposing efforts against SARS-CoV-2. To accomplish this, the authors used computational docking and molecular dynamics simulations to investigate the molecular basis for binding of three previously reported Mpro inhibitors. There is a substantial (and growing) body of work describing the structure, function and inhibition of the main protease from SARS-CoV-2, but the claims of how the current results will become part of that effort are overstated in the manuscript.

      The major result of this paper is the efficient use of the new macromolecular femtosecond crystallography setup at LCLS-II: two high resolution structures were reported from <5 hours of instrument time (1.9 and 2.1 Å). The major weaknesses of this paper stem from both the disconnected nature of the primary results and the rigor of some of the analyses. Specifically: 1) the reported structures have little relevance to drug repurposing efforts (the stated goal of the paper), 2) the differences between prior conventional structures and the analysis of the molecular dynamics simulations lack rigour, by lack of comparisons of electron densities and estimations of convergence/significance 3) the implications of the new Mpro models and/or the molecular dynamics simulations for inhibitor design are not articulated, 4) the compounds highlighted have been reported as promiscuous covalent inhibitors.

      Some of the results described in this manuscript may be of interest to the SFX community, particularly if revised to more solidly compare to existing data. However, to maximize the relevance to the wider structural biology and SARS-CoV-2 research communities, the manuscript should be revised significantly.

      Elaborating on point 2 above:

      1. The manuscript does not present a fair comparison of structural information obtained from SFX versus traditional crystallography. Electron density maps are only presented for the SFX structures (e.g. Fig. 3B). Claims of structural differences would be stronger if the structural comparison was performed using crystals grown from the same conditions and with data processed/refined/modeled in a consistent way. Isomorphous FO-FO electron density maps would be particularly helpful.

      2. The authors restrict their comparison to a single previously reported structure of Mpro (e.g. 6WQF). They should extend this analysis to the ~240 previously reported structures of Mpro from SARS-CoV-2. The majority of these structures were determined using cryo-crystallography and have ligands bound, however the comparison would still be informative, and is required for their claims of novelty. In particular, active site flexibility upon ligand binding has previously been characterized (e.g. Figure 1C of https://www.nature.com/arti..., Figure 4 of https://www.nature.com/arti... "https://www.nature.com/articles/s41467-020-16954-7)") - it would be helpful to know whether the structural differences reported by Durdagi et al match those previously reported.

      3. The structural differences involve alternative side conformations of non-catalytic residues in the active site (e.g. Figure 2B and D). Importantly, no specific link is articulated between the alternative conformations identified and Mpro function or inhibition. The authors suggest that the new structures will help modeling efforts (e.g. P5 L20, P11 L5). The authors present modeling efforts in this manuscript. How have the structural differences identified by the authors helped their modeling efforts (compared to the previously available structural information)? There are obvious computational analysis controls here that are missing.

      4. The catalytic histidine is modeled with a flipped side chain in 7CWB compared to 7CWC, however, this difference is not mentioned in the manuscript. Are the authors confident in their modeling? Looking at previously reported apo coordinates (e.g. 6WQF, 6YB7), both conformations have been modeled. The conformation modeled in 7CWB seems more compelling, based on the ability of His41 to H-bond to Cys145, and the H-bond with Wat441. The authors claim that Wat441 (W5) plays a crucial role in catalysis (P5 L28). Flipping His41 disrupts the Wat441 H-bond network, however this is not mentioned. If the authors are confident in this difference, then they should summarize their reasons and the implications for Mpro function and inhibition.

      5. A substantial and growing body of work (e.g. https://scripts.iucr.org/cg..., https://scripts.iucr.org/cg..., https://pubmed.ncbi.nlm.nih..., https://www.pnas.org/conten... "https://www.pnas.org/content/117/8/4142)") deals with radiation damage in X-ray crystallography. Carefully designed experiments, coupled with advances in detector technology, mean that problems associated with radiation damage can be mitigated, even at room temperature. Indeed, the authors of a recent paper reporting the room temperature model of Mpro (Ref 27 in Durdagi et al - https://www.nature.com/arti... "https://www.nature.com/articles/s41467-020-16954-7)") explicitly state their efforts to mitigate radiation damage: “We grew large crystals that could be used on a home source to ensure minimal radiation damage.” If Durdagi et al are suggesting that radiation damage was a problem with previously reported data, then they need to present evidence to support their claim. One option would be to collect cryogenic and room temperature data using identical crystallization conditions, then calculate isomorphous difference maps to test for radiation damage (clearly, careful experimental design is required, and problems of non-isomorphism may be encountered). Without this experiment, claims of issues with radiation damage at room temperature are not supported by evidence and should be removed.

      6. Differences in dynamics were identified with simulations performed using 7CWB and 7CWC, despite the starting coordinates being almost identical. This strongly suggests that the simulations have not achieved equilibrium sampling. Perhaps the 7CWC model was simulated with the four residue addition at the N-terminus, and this can explain the differences? This should be mentioned in the main text.

      7. Differences are also highlighted between the dynamics identified from simulations of 7CWB and a previously reported cryo model (6WQF) and room-temperature model (6Y2E). As with the previous point, these coordinates are almost identical, and if simulations of the same coordinates produce different results, how can the authors be confident that simulations with different compounds will produce useful results?

      James Fraser and Galen Correy (UCSF)

    1. On 2017-03-06 03:22:17, user ale wrote:

      Everything I have read on this URL is so far from the truth it’s surreal. This boils down to history, science and statistics. It is the most plausable form of nailing down any logical assumption on accuracy of reducing the probability for your origin to a demographic locus. So first the brass tax: most of you are Italians or have a significant genotype that is from the Italo Peninsula origin. Sorry, it’s the truth. I have been told this story by too many orthodox Ashkenazi as well as paleoanthropologists whom specialize in gene characterization. Being told this was not enough, so I researched it. Being a decendant of a Hebrew Tribe on my mother’s Sephardic Side from a family whom immigrated to Naples from Spain, we were traced by the Nazi Germans during WW2. Thus my family resided in a potato cavern behind a wall of an old farmer for two years before the war ended and were allowed to come to America. I did my due diligence and upon returning to Abruzzo visited a cousin whom happened to be on the accounting staff of the Vatican. This allowed me some leaway to utilize the Vatican library during my summer visits to truly understand my origins as an Italian-Jew. And what I leaned was right in line with science and history. My family originated from Spain, they were merchants whom specialized in the fishoil business to light lanterns. They had lived in Spain for almost 700 yrs generation to generation. Many were knights, nobleman, schlolars, lawyers and artists. I had a sample of my blood DNA analyzed and asked my mother and a few of my cousins to do the same. We all had the id mtDNA mitochondrial of Ashkenazi. But I always thought they were eastern EU and Germanic so I was confused because we were expecting to confirm some Sephardic lineage. We were wrong and I ventured to the local temple in a town nearby my mom’s hometown for further elaboration and I heard the story from an orthodox rabbi whom then was 101 yrs old. It was something out of the movies, and I will never forget his hand on my shoulder and smile and words “we are all related, so be nice to all.” The Romans who finally destroyed the second Temple of Jerusalem during Exodus led many Jews to live amongst the Romans in Rome and surrounding towns. Many were men who took Italian wives as they garnered citizenship as members of Rome. Some of the Rabbi’s own family he could trace to Poland now and Lithiania. Many of these same Jewish lineages were Italian/Hebrew, of which a small population left Italy during the Gaulish Invasions and found refuge amongst Northern Europeans. The spread out as a gypsy flock of people to Germanic states to settle down and form sub demographic and distinct cultural diaspora. That aside, each and every one of them, including yourself if you are from the eastern EU will find N1b2, M1a1b, K1a9 and perhaps even the major K1a1b1 genotype in your makeup. Yes, all origins from the Ibernian peninsula…(aka Italy). It was Exodus, you see. And the first stop was Rome of course. Romans were efficient at using the spoils of war for work and where better than the big apple itself? So, “I am who I am”. But you and I and most other Jews share almost an 80% statistical probability that the remnant non middleastern 49% of our genetic makeup is of Italian origin. This is the truth, this is what I learned. We are all connected and we all originated from two locuses, Israel and Italy. It all makes sense, think about it. Really think about it.

    1. On 2023-02-06 02:08:53, user Susan C Kandarian wrote:

      1. page 13, line 6, "(as in Figure 3C)" please correct to "(shown in Figure 4J)"
      2. please discuss implications of increased TLR4 and TLR5 in monocytes from patients. Are these gene expression changes responsible for the difference in the "DNA sensing pathway" indicated in the figures?
      3. The "TNFalpha signaling via NF-kappaB" is plotted in 3 figures but it is not referred to anywhere in the text. Is this what is meant by the few text references to inflammatory signals? Please expand on which gene expression changes were strongest in calling out this pathway by the gene cluster analysis program.
      4. Related to the above comments, it would be helpful (where possible) to state some major gene expression changes that likely caused the bioinformatics programs (KEGG or GSEA) to call out pathways such as TNFalpha signaling, IFNalpha response, etc)
      5. If you search the dataset for individual genes, like other PRRs (besides the 2 TLRs found), are there others whose expression was changed in patients such as the RIG-I like receptors that can be found on monocytes?

      I think this work on scRNAseq in different immune cell types is an important advance, but realize that scRNA data alone are difficult for making conclusions about biological processes. The monocyte data (normal vs diseased) are compelling, and they are consistent with other data indicating a problem in innate immune cell function (detection of PAMPs or DAMPS and/or an innate immune cell signaling loop error?). Perhaps it is triggered by exertion products since even ATP or ischemia-reperfusion are known activators of the PRR called NLRP3.

      I have no ideas about how to understand the messaging to macrophages since they are mostly in tissues. Lymph node biopsies?

    1. On 2022-12-18 11:06:58, user Scott Cameron ???????????????????????????????????????????????????????????? wrote:

      Couple of corrections needed in your paper here folks. Reference 24 did conduct ADP stimulation of human AAA platelets (supplemental Figure 2 — no difference). Also GP2B3A activation was assessed in AAA (Figure 2C — increased).

    1. On 2016-09-01 19:18:38, user Erik Lindahl wrote:

      Hi Steven!

      Thanks for the feedback. You are entirely right that we should have used newer CPU nodes - we just hadn't gotten our new machines delivered when we wrote the first version. However, we got a bunch of brand new dual Xeon E5-2690v4 nodes this summer (and also realized the GPU version needs two SSDs in RAID0 to really shine), so we have more up-to-date numbers now. Unfortunately, new x86 CPU cores are not significantly faster (in particular not if your code doesn't benefit hugely from FMA instructions in AVX2). You can get _more_ cores per socket (at higher price), but the performance per core will not be much faster, both because the architecture has not changed a lot, the clock frequency trends downwards, and most importantly - all those cores in a single socket share memory bandwidth (so the memory bandwidth per core is sadly dropping). When comparing ten such latest-generation x86 nodes with a total of 280 physical cores (560 threads with hyperthreading) against a single-socket workstation with 4 GTX1080 GPUs, the latter single machine is more than twice as fast as the ten nodes (see attachment). The cards should be in stock pretty much everywhere, and a colleague just got a quote for a complete workstation with GPUs for just over $6000, available now :-). In my (admittedly non-neutral) opinon the relative advantage when running actual refinement is remarkable, in particular in terms of price/performance.

      Our goal is simply to achieve massive speedup for data processing, and we are not married to any particular architecture. Relion will support them all, long-term too, and of course we hope to extend the impact beyond GPUs when possible. All changes in the code that are applicable to the CPU side have been implemented there too; when it comes to floating-point models double precision turns out to be just-so-slightly faster on the CPU, so it seemed fair to use the fastest alternative (but the difference is small). We hope to look more into the CPU side too in the future (in particular to help older hardware), but to be honest: right now we don't see any scenario where CPUs can become anywhere close to competitive for new investments, no matter how much work we invest in CPU acceleration for image reconstruction.

    2. On 2016-09-20 22:10:00, user Ross Walker wrote:

      Given the discussion on hardware here I thought I'd add a link to the Exxact preconfigured Relion GPU systems for those that are interested: http://www.exxactcorp.com/r...

      These can be fully customized and can include GeForce or Tesla GPUs. The machines (including GPUs) are warrantied for 3 years even if equipped with GeForce and the QA process includes validating all GeForce cards for numerical correctness which has been very successful in the MD and other Life Sciences fields.

    1. On 2015-11-06 15:30:45, user Benjamin Voight wrote:

      FYI - not sure if this is due to the comment below, but The google spreadsheet link in the supplement (pg. 35, section 4.11)

      to the 3230 pLI genes is broken (as of 11/06/2015, 10:26AM)

    1. On 2019-12-02 04:42:29, user Andrew Brooks wrote:

      Thanks for the update. How did you measure the distance to the membrane. There is no membrane in ref 35. Just asking if this would depend on the prediction of where the JAK2 surface is associating with the membrane.

    1. On 2020-02-02 03:41:00, user jay wang wrote:

      I BlastPed the region that spans the first 2 “insertions”, and found no so called insertions at all in the alignments with other bat-cov viruses. On the contrary the alignments showed very natural diversities around the two ”insertion” regions. The two “insertions” are obviously products of evolution,not engineered artifacts! Furthermore,even human has huge number of proteins that are homologous with those of vegetables,so why it is a surprise that there are short homologous regions between 2 viruses?

    2. On 2020-02-01 07:48:14, user ngschen wrote:

      This paper is fake. I aligned all 4 insertions. 3 of them share with BAT sars-like virus (GISAID no.: BetaCoV bat Yunnan-RaTG13 2013 EPI_ISL_402131). The fourth insertion (CTCCTCGGCGGG), which is the only one 2019-nCov specific insertion, has the best match to Marine virus AFVG_250M1136. Since the 2019-ncov outbreaks from the seafood market, the possibility of marine virus rcombination might be much more persuasive.

    1. On 2022-10-15 09:35:56, user Iratxe Puebla wrote:

      Review coordinated via ASAPbio’s crowd preprint review

      This study has developed a tool to characterize small molecule modulators of RNA-protein binding events. Please see below a few points which may help strengthen the manuscript.

      • The term “temporal” is used multiple times in the paper, to facilitate clarity for readers from different disciplines, it may be useful to provide some further explanation or context for the term.

      • Introduction section, “independent datasets have failed to reach consensus”, please provide some brief explanation about those independent datasets mentioned.

      • Introduction section, last paragraph “We apply TRIBE ID to profile cytoplasmic G3BP1-RNA interactions …” - further explanation of these three processes linked together would be helpful.

      • Figure 1, please provide some further explanation for the difference between TRIBE and TRIBE-ID. Since the dimerization is forced by rapamycin, a control experiment to explain artifact binding would be helpful.

      • In the section, “Rapamycin-mediated dimerization of G3BP1-FRB and FKBP-ADAR”, recommend adding some clarification about the goal of this experiment, which could be understanding either native processes or in a rapamycin-dependent manner.

      • In section, “G3BP1 TRIBE analysis with human and Drosophila ADAR2 catalytic domains” - suggest commenting on the reasoning for ideal ADAR to possess characteristics like “high editing activity when dimerized or fused to G3BP1”. Are these characteristics important to increase signal/noise ratio in the assay? Also, an explanation of T375G mutation and control experiments with wild type ADAR for any inhibition effect for Figure 2 would be helpful.

      • In the section, “Temporally controlled G3BP1-RNA interaction analysis with TRIBE-ID”, please clarify whether the experiment described in Figure 3 provides information about the time of interaction between RNA and G3BP1.

      • A paragraph describing any limitations and other possible applications of this tool on other systems would add to the manuscript.

    1. On 2013-12-24 21:36:22, user B. Schwessinger wrote:

      In the introduction you are suggesting the following: <br /> 'If true, conservation of important effector-target interactions<br /> may form another important means besides convergent evolution, by which targeting of<br /> important host proteins by divergent pathogen effectors, is achieved.'<br /> Do you mean that effector-target interactions might be evolutionary conserved between fungi, phytoplasma and oomycete.This seems rather unlikely given the evolutionary distance between these pathogens.

    1. On 2023-05-22 22:45:16, user Fraser Lab wrote:

      Summary:

      In protein engineering projects, it is always desirable to screen as efficiently as possible. Screening a relatively small number of variants becomes especially important when enzyme activity cannot be coupled to a high throughput sequencing readout. The major goal of the paper is to provide a proof of concept scoring and filtering system for selecting among proteins generated using computational methods to meet this challenge of efficient screening. They consider proteins generated using 2 machine learning methods and one phylogenetic method (ancestral reconstruction).

      The end result is a scoring filter combining the language model ESM-1v (which uses only sequence information) and the deep learning method ProteinMPNN (which is trained directly to find the most probable amino acid for a protein backbone predicted by AlphaFold2). After accounting for some simple idiosyncrasies of merging generative models with reality (ensuring starts with Met, removing repetitive sequences, accounting for localization signals) with heuristics, their filtering steps results in an enrichment of active sequences.

      The major success of the paper is a pipeline that actually works for selecting active sequences both in the experiments they conduct and (to some extent) literature examples. The table of potential protein failure modes is particularly useful as a baseline approach and reference for people designing sequences with computational methods. It is especially insightful to see how few deliberate filtering steps in the training process can have a big change in the outcome.

      We expect that a combination of sequence and structure-based filters will be used for prioritizing screening resources in the future. This paper lights the way of how to do that. The next steps will be to take into account structural features beyond stability (which is presumably covered by the AF2/ProteinMPNN), such as catalytic residue positioning, pocket size complementarity to substrate, etc. These are presumably implicitly captured by ESM-1. The next logical step (beyond this paper) is to go beyond statistical combination of these two scoring features to account for such features explicitly or with a new integrated deep learning approach.

      Major points:

      We are a bit confused about the exact value and sequencing of each part of the selection/filtering pipeline. We interpret experiment 3 as:<br /> Apply ESM-1v and Quality Filters and then apply a ProteinMPNN filter on top of that. <br /> Select Negative Controls by selecting sequences that fail the first filter (ESM-1v and Quality Filters) but are within 1% sequence identity to the closest natural sequence for some positive.<br /> The quality checks discussed in the supplementary information seem to have substantial impact. If the selected control sequences failed this quality check, it’s not clear whether the success of the pipeline is due to these heuristic quality checks or due to the computational filtering. These filters are biologically simple such as starting with a methionine, removing long repeats and not having a transmembrane domain - and it is kind of amusing to one of us (JF) that generative models have these pathologies so commonly. More discussion on why these filters were applied and what the distribution of effects were for the quality filters vs the insilico filters would help clarify the impact of each stage.

      This confusion then extends to determining how each of the two computational methods affect the selection. The authors contend that “no single metric would be sufficiently generalizable to screen against multiple sequence failure modes” and hypothesize that ProteinMPNN and ESM-1v “may capture distinct features.” However, because negative controls were selected only after failing the initial ESM + Quality Filters, its impossible to know what effect adding ProteinMPNN on top of ESM had. This is even more relevant given that the structures used to obtain proteinMPNN scores are first generated with Alphafold. Alphafold can be computationally intensive (expensive to run) and therefore it is imperative that we understand how much this part of the pipeline contributes to the overall success of the selection process. The authors themselves contend that “Structure-supported metrics, including Rosetta-based scores, AlphaFold residue-confidence scores, and likelihoods computed by neural network inverse folding models, take into account protein atom coordinates potentially directly capturing protein functionality, however, they can be impractical to compute, especially when evaluating thousands of novel sequences.” This is something that can potentially be teased out. In the case of the paper only 200 proteins were selected using ProteinMPNN, however, if many sequences end up passing the ESM filter and budget allows it would be within reason to expand this random ESM selection.

      In summary, it is a bit hard to tell (without some ablation studies) which different pipeline components and filters drive the results. Additionally, it would have helped if these same quality filters were applied in Round 2 but that doesn’t seem to be the case? A deeper discussion on the selection of quality filters would also point the way forward with combining more “functional” structural features as outlined above.

      Minor points:

      1) The author’s generalize the results with a few literature examples: “similar results were obtained by independently validating COMPSS on previously published datasets of six enzyme families generated by models not considered in the present study.” Looking at the results in more detail reveals that some of these (including one that we generated!) are very small samples and this caveat should be discussed. In 3 out of the 6 studies, only 1 sequence was selected by their pipeline. In another of the 6, 2 were selected. In all 4 of these studies, a number of actives were missed. The limited number of selected sequences makes it hard to know how effective the pipeline really is in these 4 studies. Further, with such a stringent filter is not practical especially when we consider the fact that the authors don’t discuss the level of activity across positive and negative active compounds. It’s entirely possible that you could miss very active sequences and select only moderately active sequences. In one retrospective, the results were truly similar, however in the last other study, the filters worked far from intended.

      Even more, my team has observed in its own work that the sensitivity of machine learning models for scoring can be heavily dependent on the sequences the models have seen before. It would have been useful for the authors to consider how the tested enzymes overlap with the model training data to understand whether these scorers generalize outside the models training distribution.

      2) The authors largely discount natural sequence identity as a metric:<br /> “Surprisingly, neither sequence identity to natural sequences nor AlphaFold2 residue-confidence scores were predictive of enzyme activity.”

      I think it’s important to qualify this with the fact that we are looking at sequences in the 70 to 90% range with very little dynamic range here. In their first experiment they looked at sequences in the 70 to 80 range. in their second they look at sequences in the 80 to 90 range. In their third experiment they looked at sequences in the 50 to 80 range but their filters end up selecting for sequences in the 70-80 range anyways. So it’s possible that locally, identity might not select for select for activity but globally, it could be a first filtering step on its own (which maybe is obvious and hence why it’s not more qualified?). Also to note is that sequence identity seemed to fare as well as or better than other metrics in identifying functional GAN-generated sequences and could be its own generative method:

      More problematic I think is figure 3f and figure 3g:

      It seems like the inactive controls are largely in a separate part of the tree compared to the active sequences passing and control. Does this have anything to do with the fact that these features failed the sequence based quality filters. Second,it suggests an approach where if you have some idea of where to focus on in the tree you could use sequence identity to those natural sequences as a metric for selection . Of course this information may not be readily available but the authors should discuss whether we could have hypothesized that the failing controls would have failed beforehand by considering their phylogenetic origins.

      Technical points:

      1) There is some problem with this sentence:

      “CuSOD training sequences had only a single Sod_Cu domain, while MDH had an Ldh_1_N followed by an Ldh_1_C domain and no other Pfam domains that generally only rarely occur in 6.3% and 1.7% of sequences in both families, respectively.”

      It’s much better captured in the supplementary material:

      “For CuSOD, 1,632 out of 25,701 proteins (6.3%) had aberrant architectures. For MDH, 1,127 out of 65,639 (1.7%) had aberrant architectures.”

      2) It’s not clear where/how they selected the natural test sequences for rounds 1 and 2. We assume it’s from the curated set of data but that’s not necessarily a given, further it seems that in round2, sequences were selected to span the range of esm scores. Was this done for the test natural sequences as well?<br /> “Only 13 test natural sequences were selected, as we had already screened five similar natural sequences in the remediation for Round 1.”

      “Besides the identity range, the experimentally tested sequences were selected to span the entire range of scores on each metric (Supplementary Table 4)”

      3) The authors should be more explicit on the natural sequence identities in each round. If you check the supplement you can find this information if you pay attention to the figures or check the supplement but I think that it should be explicitly stated in the section “Round 2: Calibration data for COMPSS” that sequences are selected in the 80-90 range and in Round3 that the filters resulted in sequences with >69% identity.

      4) The following section is confusing:

      “To further test the hypothesis that poor truncation selection was responsible for the lack of observed activity in the Round 1 CuSOD natural test sequences, we assayed an additional 16 natural SOD proteins (pre-test group)…”

      It should be stated at the beginning that 14 of the 16 test sequences are CuSOD sequences and 2 of the sequences are FeSOD sequences vs letting the reader figure that out later in the paragraph. Additionally, it would help the audience to say explicitly that 3/7 bacterial sequences with clipping also passed or include the table from the supplement up front. 3/7 doesn’t seem clearly distinct from 4/5.

      5) What’s the reason for changing the esm-msa sampling method in round 2? Did they observe some benefit or was this purely a computational choice?

      6) I think the text for a and b are switched in the figure 2 description. a is the AUC figure and b is the correlation figure. Further for figure a If the test sequences are natural sequences, is the identity score meaningless here?

      7) From the supplement: “We skipped the 'starts with M' filter because very few of the sequences in these sets start with M, and did not subset by identity to closest training sequence.” This modification to the pipeline should be mentioned in the discussion of the external validation tests. Or they should speculate what would happen if they just added a M at the beginning of every sequence?

      8) Looking at the figures in the supplement e.g. Fig 30 it seems like they had quantitative activity values. It would have been nice to discuss if there was any correlation between scores and activity for ranking purposes. Was this not included because of variance in the assay?

      Joel Beazer (Profluent) and James Fraser (UCSF)

    1. On 2016-11-08 16:45:38, user Kasper Hansen wrote:

      Skimming this, I am surprised there is no discussion and comparison to Finucane (2015) Nature Genetics. From my understanding Finucane et al basically solves the same problem, accounting for the same factors as GARFIELD attempts to account for.

    1. On 2020-06-03 16:25:39, user tomas.blisset wrote:

      Hi, there is a mistake in equation (11), The steady-state decay time:

      t_eff = Tm*t_a / (Tm + <h>)

      instead the reported equation is:

      t_eff = Tm*t_a / (Tm + t_a) ( which is also incorrect dimension-wise)

      Thanks for the paper, very nicely written and meaningful.

    1. On 2017-03-30 13:13:47, user Jamie Timmons wrote:

      Hi Benjamin

      Thanks for your response to the discussion on the incorrect assessment of our work by Jacob and Speed.

      I wondered if you could expand on your posting and update it with the essential information?

      Jacob original stated that he ranked our training data set for differential expression by age and sampled "randomly" from the top 25%. No code was presented and the R code itself doesn't need to reflect the input data matrix or indeed be what was actually used.

      Jacob and Speed have refused to answer any questions or share code for the past year.

      We did carry out 10,000 random samples from the U133+2 with and without our 'model probe sets' and beyond any doubt their claims are false for tissue age classification. No random 150 remotely matches our signature.

      The remaining analysis by Jacob is scientifically invalid as it 1) combines clinical groups that can't be combined and 2) it relies on 'other' gene lists out with any into all model. Anyone can fit a unique list to a given data set. No one has taken 1 model and made it work nicely across 7 independent data sets....hence our paper.

      I'd like to learn more about the route you took to establish your opinions on Disqus and if you can share any materials with my team?

      Thanks<br /> Jamie

      Professor James A Timmons

    1. On 2013-11-18 23:54:52, user Matt MacManes wrote:

      Thanks Kristian for the comments. I can add P30. I didn't as it seems this is not a commonly used threshold.

      Also, I could start y-axis at 0- I just worry that doing this makes the plots, especially the differences between the different sized datasets more obscure.

    1. On 2021-04-20 15:22:21, user Alex Sobko, PhD wrote:

      Dr. Alex Sobko, PhD. Fascinating article and innovative approach to targeting transcription factors! Congratulations! The only criticism that I have - ERG binding moiety used to design O’PROTAC – ACCGGAAAT within a 19-mer double-stranded oligonucleotide containing the sequence of ACGGACCGGAAATCCGGTT. This sequence represents Class I of ETS proteins, containing more than half of the ETS family (PEA3, TCF, ETS, ERF, and ERG subfamilies), displays a consensus sequence identical to the most common in vitro–derived sequence (ACCGGAAGT). <br /> Reference: Hollenhorst PC, McIntosh LP, Graves BJ. Genomic and biochemical insights into the specificity of ETS transcription factors. Annu Rev Biochem. 2011;80:437-471. doi:10.1146/annurev.biochem.79.081507.103945

      This brings to mind a question of redundant and specific occupancy by ETS factors, including ERG. Is it possible that target sequence binds other TFs, in addition to ERG? If so, it is less specific than one would wish!

    1. On 2021-11-17 22:50:42, user Mattia Deluigi wrote:

      Congratulations on this major breakthrough. The new cryo-EM structures of inactive-state GPCRs are a great advancement and certainly overcome several inherent limitations of crystal structures, which so far have been the only way to solve these receptor conformations. However, we would like to point out two issues with the current version of the manuscript:

      1) To compare the cryo-EM approach with crystallography, the new cryo-EM structure of the hNTSR1:SR48692 complex is compared with a crystal structure of rNTSR1 bound to the same ligand, which has recently been reported by our lab (ref. 16; DOI: 10.1126/sciadv.abe5504; PDB ID: 6ZIN). However, we have to note that an essential part of our work was not considered in this comparison of cryo-EM and crystallography, resulting in (i) a potentially misleading description of some differences and (ii) an unnecessary downplay of the crystallographic approach.

      As mentioned by the authors, most crystal structures of GPCRs require prior protein stabilization. This has also been the case in our study, which resulted in a first structure of the rNTSR1:SR48692 complex (PDB ID: 6ZIN) using the NTSR1-H4<br /> mutant. However, we realized that four stabilizing mutations were likely to affect some of the receptor structural features. Thus, in the same study, we reverted those four mutations to the wild-type residues, giving rise to NTSR1-H4bm and a second structure of the rNTSR1:SR48692 complex (PDB ID: 6Z4S). The structure of this back-mutant represents a more native-like rNTSR1:SR48692<br /> complex, obtained already prior to the cryo-EM structure. Consequently, we believe that a fair comparison of the cryo-EM structure with a crystal structure requires the consideration of the back-mutant in the first place, which is not the case in the current manuscript. Comparison with the back-mutant would allow, e.g., a better discrimination of which differences naturally occur between human and rat NTSR1, which is crucial for drug design.

      Thus, some structural aspects detailed in the current manuscript need to be reconsidered:

      • The difference in the position of TM1. As stated in our study (ref. 16; DOI: 10.1126/sciadv.abe5504), we suspected that the position of TM1 was affected by crystal packing forces in the structure of NTSR1-H4. However, this is not the case in the back-mutated construct (NTSR1-H4bm), as has been nicely confirmed by the cryo-EM structure. The conformation of ECL2 and the intracellular half of TM7 are also more native-like in the back-mutant structure (the difference at Y7.53 between cryo-EM and crystal structure discussed by the authors is nonetheless present, and we agree that the DARPin fusion can influence the NPxxY region).

      • The differences in the residues beneath the ligand’s carboxylate group (e.g., 6.51, 6.54, 6.55, 7.42). We reverted the mutations at positions 2.61, 3.33, and 7.42 to their wild-type counterparts explicitly to provide a more native environment in these regions. Accordingly, the differences between the back-mutant structure and the cryo-EM structure are smaller or absent. It should also be considered that the cryo-EM and crystal structures could have captured partially different inactive receptor conformations.

      • In the structure of the back-mutant, we were able to model ECL3 and the sidechains of F344(7.28), Y347(7.31), and W339(ECL3) (although the electron density for the latter was weak). Nonetheless, as pointed out in the preprint, some differences in the sequence between human and rat NTSR1 probably induce a slightly different conformation of the extracellular tip of TM7 and ECL3. The description of these differences is of great relevance to drug design.

      Crucially, the ligand-binding mode is nearly identical in the cryo-EM and crystal structures underlining the validity of both approaches. In addition, the observation that the inverse agonist SR48692 is accommodated in a substantially wider binding site compared to the agonist-bound structures, as pointed out in our study, has now been nicely confirmed. It is correct that the gain of knowledge from the crystal structures of our engineered NTSR1-DARPin fusion is mostly limited to the extracellular receptor portion — as explicitly stated in our study — and that the cryo-EM structure now overcomes this limitation (e.g., by describing the Na+ pocket) and confirms the validity of the ligand-binding site.

      2) The second problem is related to the comparison between the density of the hNTSR1:SR48692 cryo-EM structure and the electron density of the rNTSR1:SR48692 crystal structure. While the quality of the density in the cryo-EM structure certainly allows<br /> one to overcome the limitations of the crystal structure (e.g., modeling of ECL1, Na+ and H2O), we believe that the current<br /> comparison is not entirely fair.

      If the crystallographic 2Fo–Fc map for the ligand (Fig. 2b) is contoured at a typical sigma=1.0, it also clearly features the chlorine atom of the chloroquinoline ring of SR48692. This is also true for the structure of the back-mutant mentioned above (PDB ID: 6Z4S), see fig. S5D and fig. S11A in ref. 16 (DOI: 10.1126/sciadv.abe5504). Thus, we believe that a fair comparison must include the 2Fo–Fc map contoured at sigma=1.0 and not only at sigma=1.25. In the end, it should be acknowledged that the electron density maps allowed unambiguous modeling of the ligand, and indeed the ligand-binding mode is nearly identical in the cryo-EM and crystal structures. To reiterate point 1 above, a comparison with the back-mutant in the first place makes more sense, and it does not reduce the impact of the cryo-EM structure (although the differences are vanishingly small, the ligand also adopts a more native binding mode in the back-mutant). Compared to the non-backmutated structure, the resolution of the back-mutant is very similar (2.71 Å), and the quality of the electron density allowed unambiguous modeling of most key residues (see fig. S12, A–C, in ref. 16 (DOI: 10.1126/sciadv.abe5504)).

      Minor suggestions:

      • In the legend of Fig. 2d, “ECL2” should be corrected to “ECL3”.

      • In the legend of Fig. 2e, “rNSTR-H4” should be corrected with “rNTSR1-H4”. Note that in the back-mutant (PDB ID: 6Z4S), the F7.42V mutation has been reverted to the wild-type Phe residue.

      • “Fig. 2c” should be corrected with “Fig. 2d” at the end of the following sentence: “First, the remodeling of the TM7-ECL3 region allows W334 in ECL3 to be resolved in the hNTSR1 structure loosely capping the top of the hydrophobic chloro-naphthyl and dimethoxy-phenyl moieties of SR48692 (Fig. 2c).”

      • In Extended Data Fig. 3, the legend of panel a actually describes panel c. The legend of panel b describes panel d. The legend of panel c describes panel b. The legend of panel d describes panel e. In the name of the crystallographic construct, a hyphen is missing between “NTSR1” and “H4”.

      • In both the main text and Supplement, “NTSR” is sometimes written instead of “NTSR1”.

      Best regards,

      Mattia Deluigi, Christoph Klenk, and Andreas Plückthun

    1. On 2023-06-09 18:05:22, user Stacy Clark wrote:

      The authors state that 'disease resistant' trees have been developed through hybridization and genetic modification'. This is inaccurate and misleading. The hybrids are not yet fully blight resistant, according to TACF's own data and other publications. The GMO chestnut has been shown to be resistant in very short time periods and in very restricted environments. They do not exhibit durable resistance. I suggest they change the wording accordingly to better reflect the reality of the current situation or cite papers that show durable resistance.

    1. On 2014-03-29 16:34:11, user Russell Dinnage wrote:

      A typo in the Abstract, last sentence: 'improves eplicability' I assume should be 'improves replicability'. This is a great idea, thanks for posting as a preprint so we can start using it sooner (if it is as good as it sounds). Now to read the paper and find out!

    1. On 2021-03-16 19:16:38, user Anandi Krishnan wrote:

      Posting here a unique context to this work that might be helpful for some:<br /> this preprint is the first and major culmination of a unique research re-entry award to A.K. by the NIH (specifically, the National Center for Advancing Translational Sciences, NCATS but also available from other institutes). The research re-entry awards are designed for those experiencing life-related interruptions to their careers – and for me, this work would not have been possible without this unique NIH mechanism (that has now facilitated a subsequent NIH/NHGRI career development award). Please visit this NIH link for details if interested in these diversity/re-entry supplement awards: https://ncats.nih.gov/ctsa/....<br /> More of the backstory here: https://twitter.com/anandi_...

    1. On 2023-05-15 09:26:21, user Martin wrote:

      Dear S Denagamage, M Morton and A Nandy,

      It is a very interesting study you report here.<br /> I noted that you use a delayed saccade task such that the probe was presented either 450 to 950 ms before the saccade (with an average saccade latency of 150 ms).<br /> Using a design adapted to human non invasive behavioral measures we found (Szinte et al, eLife, 2018) two spotlights of increased performance with a similar timing (that might correspond to the CF and FF positions and the forward hypothesis) but no real FF when the probe was presented in the latest instant preceding the saccade execution (effect that might correspond to the convergence hypothesis). We speculated that remapping mechanism are orchestrated by spatial attention (Colby et al 1998) and thus takes time to develop. In this interpretation, convergent remapping reflect the response to the saccade target which is presented earlier in time. <br /> Did you analyzed your nice multi-layer results as a function of the probe onset relative to the saccade onset ? I would predict a less clear forward remapping for the shortest durations (consistent with Zirnsak et al study who had very short durations).

      Best regards,<br /> Martin Szinte

    1. On 2018-02-15 14:43:17, user Chris Balakrishnan wrote:

      And my first preprint comment! And it is the worst type, request for self-citation. But I really i would just suggest resolving whether you mean redundancy or degeneracy. We talk about the distinction a bit here: http://rspb.royalsocietypub... If you disagree with distinction of course let use know! This is a very interesting study

    1. On 2025-08-01 20:29:38, user Roel Nusse wrote:

      Rebuttal to Claims Regarding Reproducibility of Our WntD and Edin Studies<br /> Michael D. Gordon1, Janelle S. Ayres2, David S Schneider3 and Roel Nusse3<br /> 1. University of British Columbia<br /> 2. The Salk Institute<br /> 3. Stanford University

      We write in response to the preprint by Lemaitre and colleagues that challenges the reproducibility of our published findings on wntD (Nature, 2006) and Edin (PLOS Pathogens, 2008). While we welcome efforts to independently validate and extend prior findings, we believe that the conclusions drawn by the authors are not supported by rigorous replication and, in several key respects, reflect significant experimental and interpretive flaws.

      Mischaracterization of the wntD Mutant Allele

      The preprint by Lemaitre and colleagues centers on the observation that our original wntD allele reproduces the published phenotypes, but a second allele does not. The authors infer, based on quantitative PCR in early embryos, that our stock must have lost the mutation and that the observed effects are due to background variation. However:

      • The qPCR assay used by Lemaitre and colleagues is technically invalid for assessing the integrity of our allele. As clearly described in our original work, our wntD mutant was generated by insertion of a w+ cassette into the wntD coding region—leaving the 5´ portion of the gene intact. The primers used by the authors target this unaffected region and are therefore expected to detect RNA transcripts, even though the resulting mRNA is non-functional. This is a fundamental flaw that undermines their central argument.<br /> • The authors did not attempt genomic PCR or sequencing to verify the presence or structure of the mutant allele in our stock—an essential step before invoking reversion or mislabeling.<br /> • The phenotypes associated with the original wntD allele were in fact replicated in their hands, contradicting their own assertion of irreproducibility. The failure of a second allele, generated in a different background and evaluated under different conditions, does not constitute a failure to reproduce but rather a failure to validate by independent means—a distinction that matters.

      Strain Background and Controls

      Lemaitre and colleagues raise concerns about genetic background effects while applying inconsistent standards in their own work. Our original wntD experiments were conducted in a y-w- background, and controls were matched accordingly. Their second allele appears to be in a wild-type background, yet their comparison is made to both y-w- and w1118 lines. It is well established that immune phenotypes in Drosophila can be highly sensitive to background variation. As such, a difference in phenotypes between two alleles in different backgrounds is neither surprising nor indicative of poor reproducibility.

      Misinterpretation of wntD Expression Patterns<br /> The preprint by Lemaitre and colleagues suggests that wntD is only expressed at embryonic stages, questioning its relevance to immunity. However, the Fly Cell Atlas reveals specific clusters of cells expressing wntD in the whole body, gut, and Malpighian tubule samples. Moreover, additional studies have demonstrated that wntD is in fact inducible in adult flies upon infection with either L. monocytogenes or S. pneumoniae, supporting its role in immune modulation (Chambers et al., 2012, https://doi.org/10.1371/journal.ppat.1002970 ). The claim by Lemaitre and colleagues that the field has not followed up is inaccurate.

      Edin: Distinction Between RNAi Knockdown and Knockout

      In the case of Edin, Lemaitre and colleagues observe that a knockout mutant lacks the infection sensitivity we previously reported using fat-body-specific RNAi. They suggest off-target effects as a possible explanation. However:<br /> • We demonstrated the phenotype using two independent RNAi lines, reducing the likelihood of off-target artifacts.<br /> • The tissue specificity and temporal dynamics of RNAi versus germline knockout are fundamentally different. Loss of a gene during development may engage compensatory pathways that are not triggered in an acute knockdown context.<br /> • The conditions of microbial challenge differ between studies and were not standardized, further complicating direct comparison.

      Edin Overexpression: Dose Matters

      Lemaitre and colleagues report that Edin overexpression is not deleterious in their system, but this is entirely consistent with our findings. In our original study, mild overexpression had no phenotype; only very strong overexpression (>600-fold) triggered a measurable deleterious effect. The line used in their study achieves ~50-fold overexpression and would not be expected to phenocopy our results.

      Conclusion<br /> While we support efforts to critically assess past findings, we reject the characterization of our studies as “non-reproducible” based on the experiments presented by Lemaitre and colleagues. The authors did not repeat our experiments as described, used different alleles, different controls, and in some cases, flawed assays. Differences in outcome under these circumstances are part of the normal course of scientific investigation and should not be conflated with a failure of reproducibility.<br /> We encourage future studies that further explore wntD and Edin biology, using rigorously matched conditions and appropriate validation techniques. Scientific progress depends on careful experimentation, not just reanalysis.

      Sincerely,

      Michael D. Gordon, email: mikedgordon@gmail.com<br /> Janelle S. Ayres, email: jayres@salk.edu<br /> David S Schneider, email: dschneid@stanford.edu<br /> Roel Nusse, email: rnusse@stanford.edu

    1. On 2020-10-09 17:07:42, user Aura Raulo wrote:

      Hello and thank you for your feedback! Really nice to hear that you enjoyed reading our manuscript! To answer your questions:

      • Yes you got the SRI almost right, except for a few things: As you said, X is the number of cases (night-logger combinations) where two individuals crossed the same station within the specific time window of each other. in BI, this number was just 1 or 0 for whether they were ever observed within this time window from each other. This number (either X or 1/0) was then divided by the number of cases when either one of these individuals were observed but not together. The cool thing is that for the denominator, we included only those "not-together" observations for which we were certain that the other mouse was alive then, so that technically they could have been together. This is very similar to traditional SRI, just a proportion of observations of two individuals where they are observed together, but we are essentially excluding single observations of A or B from the denominator from time periods when the other was not born yet or assumed dead. This way the social associations do not reflect just the extent to which two mice co-existed on earth, but rather how much they interacted during the overlap of their existence. Almost identical adjusted SRI is published in Firth JA, Sheldon BC. Social carry-over effects underpin trans-seasonally linked structure in a wild bird population.Ecol Lett2016;19(11):1324-32

      • "nodes" is a common social network term and means just the the nodes in the network. When using a network analysis, it's often a common practise to state what entities were the nodes and what were the edges connecting them in this network. This is because the network nodes are not always individuals, for example sometimes groups of individuals are considered a node. Or in an ecological network, a node would be species.

      • Ah thanks for spotting! Thos should be 12 hours. I will fix it.

      Thanks for such nice feedback. My co-author will be pleased to know that their snazzy supplementary material formatting received such complements.

    1. On 2016-03-10 00:09:21, user Simon Martin wrote:

      Thanks Peter. I think you're absolutely right. Unfortunately we don't really have better options to estimates error rates at this stage. Trios might offer an improvement in the near future. Many of the analyses in this study are based on four-fold degenerate third codon positions, and indels should not be too much of a problem in coding regions, so I think for this study the estimates might not be too misleading.

    1. On 2022-07-15 04:40:36, user Björn Brücher wrote:

      Insightful study and analysis. Thank you.

      Question:

      Are 3-to-8-months old mice comparable to human findings?

      The mice ages compare to humans of 20-to40 years of age, but AD and chroinic neuronflamation are found in in older humans (more comparable to mice of 15-to-30 months of age).

      Please see representative age ranges adapted from:

      Flurkey K, Currer JM, Harrison DE (2007) The Mouse in Aging Research, In The Mouse in Biomedical Research 2nd Edition, Fox JG, et al. (eds), American College Laboratory Animal Medicine (Elsevier), Burlington, MA, 637–672.

    1. On 2021-09-26 00:59:36, user Raghu Parthasarathy wrote:

      [I wrote this for the earlier version; it applies to this version also.] Interesting paper! If you're going to claim a power law (such as an inverse square), however, it would be good to see the data plotted on a log-log scale, so that the scaling exponent is obvious, and also to see a robust fitting of the exponent value. Also, I don't see that the datapoints are available to the reader -- is there a supplemental data link missing? Thanks!

    1. On 2016-05-27 22:56:18, user Albert Erives wrote:

      Note from corresponding author: We would like to cite all publications showing evidence for a direct Notch/Su(H) enhancer. If anyone knows of such a pub that is not already cited in the pre-print please contact me.

    1. On 2021-04-14 01:10:41, user stephens999 wrote:

      A review of Chris Wallace's preprint "A more accurate method for colocalisation analysis allowing for multiple causal variants", by Matthew Stephens

      Summary

      This paper introduces an extension of the "coloc" method for colocalization<br /> to deal with multiple causal variants in a region. This extension exploits a<br /> recently-introduced method for fine mapping (SuSiE). The extension is<br /> attractive in its simplicity, and simulations show it to perform better than some<br /> alternative approaches. The paper also suggests a way to speed up computations<br /> by pre-filtering out "non-significant" SNPs.

      The key idea of combining SuSiE and coloc is nice, and I think that with<br /> some improvements to the presentation will make a nice publishable contribution.

      The idea of speeding up SuSiE by pre-filtering SNPs is also attractive from<br /> a practical point of view, but it has some potential downsides that I feel<br /> are not sufficiently emphasized and explored (even though the manuscript does end<br /> with a statement that trimming might be not beneficial in general final mapping).<br /> Specifically trimming out non-significant SNPs<br /> could increase the potential for false positive identifications,<br /> and indeed such a result has been previously reported in<br /> https://www.biorxiv.org/con...<br /> (their Figure S7). It's not clear to me how, if at all, this is reflected in the results<br /> shown here. Maybe it is simply the case that, as the paper suggests in the discussion,<br /> that "Coloc benefits from comparing posterior probabilities across... two traits".<br /> But the overall way that the manuscript deals with false positive (or indeed<br /> false negative) identifications<br /> is not clear. (Maybe methods are applied with some<br /> knowledge of the true number of causal effects? It isn't clear to me.)<br /> Since there are also other potential ways to speed up computation (see comments below)<br /> I am not really convinced that the pre-filtering approach is really the way to go,<br /> and would like to see at least a stronger assessment of the potential downsides.

      Main Comments

      1. The presentation of the method requires more details, including more precise<br /> equations showing how quantities computed by SuSiE are used/combined. For<br /> example you could introduce $\alpha_{lj}$ for the matrix of posterior probabilities output by susie<br /> and then give explicit expressions for the Bayes Factors being computed<br /> ($BF_{lj}$) in terms of $\alpha_{lj}$. I'm not sure what $P_0$ is (is it something output by SuSiE?)<br /> Is $\pi=1/p$ where p is the number of SNPs in the region, or something else? How<br /> do you set the maximum number of effects in SuSiE (L in the SuSiE paper)? Do you get SuSiE to<br /> estimate the number of effects by estimating the prior variance, or do fix the prior variance?<br /> If $L_g$ is the number of effects identified by SuSiE in the GWAS and $L_e$ the<br /> number identified by SuSiE in the eQTL study, do you end up running coloc $L_g * L_e$ times?<br /> (as suggested by "for every pair of regressions across traits" on p3).<br /> How do you combine/summarise the results from all these different runs of coloc?

      2. Presentation of colocalization results also needs more details. Can you say explicitly<br /> what is an "AA" or "BB" comparison and an "AB-like signal"? From the description on p3 I<br /> thought the simulations would include settings where there were 2 causal variants in each trait,<br /> but no sharing. But Fig 3 seems to suggest<br /> only a small portion of potential configurations of up to 2 signals in each trait are actually<br /> included - is that right? (why?) And in Fig 3, what happens if SuSiE finds a signal in one trait<br /> and not in the other - what comparison do you make? (Or do you force SuSiE to find the right<br /> number of effects in each trait by fixing L to the true value? If so, is that cheating?)<br /> Is the smaller height of the AA bar for susie_0 compared with other methods -- and indeed<br /> the slightly smaller height of all bars -- something to be<br /> concerned about? Are all methods equally applicable if (as is always the case) you do not know<br /> the true number of causal signals in each trait?

      3. Figure 1 compares only the PIPs at causal variants. Since in practice we don't know the<br /> causal variants, one should also care about PIPs at non-causal variants. Is there a tendency<br /> for SuSiE to inflate PIPs at non-causal variants when trimming?

      4. It seems there are many potential ways to improve computation than<br /> filtering out non-significant SNPs, and many of them may ultimately be better choices<br /> (although filtering is obviously very simple to implement!) I don't think the discussion<br /> in the paper really adequately reflects the options available or the many<br /> issues involved.

      Although I did not see it explicitly said anywhere, I believe the<br /> paper is using the susie_rss function for applying SuSiE to summary data.<br /> The details of this function are not included in the original SuSiE publication, but I believe<br /> that at the time this work was done susie_rss<br /> worked by performing an initial eigendecomposition of the reference LD matrix R, which<br /> makes it possible to convert the summary data into "transformed data" to which<br /> regular SuSiE can be applied. This approach is appealing from a software engineering<br /> point of view, but not necessarily the most efficient, computationally. The eigendecomposition<br /> of R is quite expensive, being O(p^3) where p is the number of SNPs.<br /> The subsequent application of SuSiE<br /> to the transformed data is O(p^2) per iteration.<br /> Thus if p is sufficiently large the eigendecomposition step will likely<br /> dominate the susie_rss computation (and Figure 2 does indeed suggest computation maybe<br /> increase something like p^3?)

      One way to reduce computational complexity would therefore be to avoid the eigendecomposition<br /> step, and we are currently actively exploring these in our development of susie_rss. <br /> However, note that computing R itself is already<br /> an O(np^2) operation, where $n$ is the number of samples in the reference sample used to compute R. So<br /> if n is big then this computation (which is basically considered free<br /> in this paper since R is precomputed) could be the dominant computational cost. Alternatively<br /> if n<<p, then="" one="" should="" perhaps="" entirely="" avoid="" forming="" r="" --="" in="" the="" case="" n<<p="" an="" eigendecomposition="" of="" r="" can="" be="" obtained="" by="" doing="" an="" svd="" of="" the="" reference="" genotypes="" (o(n^2p))="" which="" will="" cheaper="" than="" forming="" r="" (o(np^2))="" when="" n<<p.="" in="" the="" future="" it="" seems="" quite="" likely="" that="" pre-computed="" r="" and="" eigen(r)="" could="" be="" made="" available="" for="" some="" large="" panels,="" avoiding="" the="" need="" for="" each="" user="" to="" compute="" them.="" once="" these="" pre-computations="" are="" done="" there="" may="" no="" longer="" be="" any="" need="" to="" filter="" snps.="" other="" comments="" details="" -="" p3="" although="" the="" number="" of="" potential="" models="" increases="" exponentially,="" susie="" computation="" does="" not="" increase="" exponentially.="" -="" p4:="" "we="" labelled="" each="" comparisons="" considered...."="" i="" did="" not="" understand="" this="" sentence.="" -="" p4:="" "...="" having="" strongest="" posterior="" support="" for="" h\_4"="" -="" this="" should="" be="" h\_3?="" -="" p8:="" "="" this="" does="" apply="" to="" single="" trait"="" -="" missing="" \*not\*?="" -="" in="" the="" second="" row-set="" of="" figure="" 3,="" is="" the="" figure="" on="" the="" lhs="" wrong?="" (the="" methods="" suggest="" colocalization="" but="" the="" figure="" shows="" no="" shared="" variant...)="" -="" on="" p7="" the="" r2="" threshold="" is="" 0.8="" but="" on="" p4="" it="" is="" 0.5.="" are="" there="" referring="" to="" different="" thresholds?="">

    1. On 2019-08-01 13:06:12, user Arne Jorgensen wrote:

      Is the influx from southern Scandinavia and Germany caused by the plague which exterminated most of the population in the 400 and 500 centuries, and the fimbul winter, caused by volcanic activity?

    1. On 2017-08-04 22:15:00, user Ailong Ke wrote:

      Page 10, line 7 from the bottom: "As Csn2 binds to the same substrate as Ku, it could interfere with NHEJ repair [Deltcheva et al, Nature 471, 602-7 (2011)]". I could not find where in this reference "Ku", "NHEJ", or "Csn2 binds to the same substrate as Ku" were mentioned.

    1. On 2020-02-05 11:13:37, user Pei-Hui Wang wrote:

      Prof. Wang Pei-Hui Lab in Shandong University, China, all orf clones of 2019-nCoV / SARS in pcDNA6B-FLAG can be requested, please contact him. Email: wphlab@163.com covering the following orfs: nsp1-16, S, 3, E, M, orf6, orf7a/b, orf8, orf9, orf14, N; and ACE2

    1. On 2016-06-27 18:32:47, user Aaron Vollrath wrote:

      Could ribosomal profiling add further information? Data derived from this approach would represent mRNA transcripts being actively translated. Perhaps there would be a correlation with those upregulated genes.

    1. On 2019-02-19 02:34:48, user Mark A Girard wrote:

      Hospital use of antibiotics is also the main driver of the enormous number of people directly harmed by antibiotics as well. People routinely get poisoned by antibiotics, in particular the fluoroquinolones, and then doctors misdiagnose the patients with lupus, fibromyalgia, ALS, Parkinson's, MS and hundreds of other wrong conditions. This is a disaster of almost unimaginable scope and scale, the Thalidomide story of our era, times ten thousand, spilling into the news cycle soon.

    1. On 2019-09-25 08:37:45, user Wouter De Coster wrote:

      Dear authors,

      Thank you for the very interesting work.<br /> While not the key message in your paper, I would just like to let you know that the error estimate for ONT sequencing (~40%) is terribly outdated, and your reference is a 10 years old paper, before ONT sequencing was even available. Current accuracy is about 90-95%. A reference for that number could be https://genomebiology.biome..., which is also already outdated since it is older than a year, but good enough for this purpose.

      Regards,<br /> Wouter

    1. On 2020-09-28 15:13:39, user Meng Cui wrote:

      Thanks for the question. We chose quartz glass for its excellent optical quality. It can be made very thin (e.g. ~15 micron) so that it produces negligible aberration for the two-photon imaging. We have not tested Teflon tubing. If they were made to such wall thickness, it may be too soft for long-term longitudinal imaging.

    1. On 2021-05-20 18:50:12, user Ian Fiebelkorn wrote:

      Brookshire reminds us of some important points that should certainly be considered. This preprint DOES NOT, however, overturn the substantial literature supporting the existence of rhythmic structure in attention-related sampling. Here are some of my thoughts on its implications:

      This title, “Re-evaluating rhythmic attentional switching: Spurious oscillations from shuffling-in-time,” and similar statements, like the following, are unintentionally misleading: “Shuffling in time often generates plausible-seeming amplitude spectra with significant peaks at theoretically interesting frequencies.” Shuffling in time does not generate oscillations or consistent amplitude spectra; rather consistent aperiodic temporal structure (e.g., when simulated) can generate consistent peaks in a DFT. Shuffling in time tests the hypothesis that there is consistent temporal structure. The question raised by this preprint is whether statistically significant peaks from DFTs reveal periodic (i.e., rhythmic) or aperiodic temporal structure. Here, the author creates consistent DFT results by simulating consistent aperiodic time-series data.

      This manuscript often uses the term “false positive.” It’s important to note that false positive here doesn’t mean that existing papers tend to report a significant result, when in fact there was no significant result. It means that such significant results could have occurred because of either consistent periodic or consistent aperiodic temporal structure in the data.

      A DFT converts time-series data into the frequency domain, measuring the sinusoidal components that need to be added together, at specific amplitudes and phases, to reconstruct a times series. Any time-series signal can be decomposed into its sinusoidal components. A peak in the DFT therefore doesn’t necessarily mean that there is a rhythmic component. For example, there could be single, high amplitude bump in the data, with a width of ~100 ms, that shows up as a peak in the DFT. But of course you could see that this was the case (i.e., that the peak in the DFT resulted from a single bump in the data) by simply looking at the shape of the function that was submitted to the DFT, which we should do when reviewing papers that test for oscillatory patterns in behavioral data.

      The same issues exist when measuring oscillatory activity in neural data. That is, typical signal processing approaches can measure significant power and phase at specific frequencies, even if there isn’t a true oscillation at that frequency (e.g., see the work from Stephanie Jones and colleagues on beta events). With neural data, we are often asked to show evidence from single trials to demonstrate that what we’re calling a neural oscillation, based on the results of signal processing, actually looks like an oscillation.

      So what does the behavioral data supporting attentional switching look like? Here, I’ve included a figure (see Twitter post) that shows our behavioral data, (A) averaged across humans and (B) from two different animals (tested during numerous experimental sessions). These data represent the difference in performance across two potential target locations (i.e., examining attentional switching). These data show highly consistent peaks and troughs across species and across individuals (i.e., the two animals). Moreover these peaks and troughs have very consistent temporal separation, occurring at a theta frequency.

      To help determine whether temporal structure in the behavioral data is attributable to periodicity in neural activity, we have to look for verification in neural data. This has been done in the rhythmic sampling literature. That is, there is behaviorally relevant theta-rhythmic activity, e.g., in the network that directs spatial attention (see, e.g., Fiebelkorn et al., Neuron, 2018; Helfrich et al., Neuron, 2018; Fiebelkorn et al., Nature Communications, 2019; Fiebelkorn and Kastner, Neuron, 2021). Ayelet Landau, e.g., also followed-up her behavioral data (Landau & Fries, Current Biology, 2012) with neural data (Landau et al., Current Biology, 2015).

      It would, however, definitely be preferable to have measures that were specifically designed to detect consistent periodic temporal structure in behavioral data, rather than measures that cannot, by themselves, distinguish between consistent periodic and consistent aperiodic temporal structure. Such measures would avoid any subjectivity.

      So are the measures presented in this preprint the right measures? From the text: “Both the AR surrogate method and the robust est. method successfully recover true oscillations in simulated behavior. These methods most effectively recover oscillations at higher frequencies and higher amplitudes.” Based on Figures 6 and 7, these methods were not good at detecting true oscillations in the low-theta (i.e., 4-6 Hz) frequency range, i.e., the range typically associated with attentional switching. So it would seem they are not the right measures for this particular research topic. If these measures don’t do a good job of identifying relatively high-amplitude rhythms in highly consistent simulated data, then they won’t identify lower-amplitude rhythms in noisier, less consistent behavioral data.

      Given this performance with simulated data, is it surprising that these methods didn’t find evidence of significant rhythms in the re-analyzed behavioral data? The author concludes: “rhythms in behavior might not be as prevalent as the published literature suggests.” Possibly, based on the fact that the approaches typically used in the existing literature might lead to false positives, meaning they say there’s a significant periodic structure when there’s actually a significant aperiodic structure. But then again, what do the data actually look like? The proposed alternative approaches, however, have the opposite problem. They can miss real periodic temporal structure in the data, particularly at the frequencies of interest for the attentional switching literature. It’s therefore not fair to conclude, based on the analyses in the present preprint, that these re-analyzed studies do not have rhythms in their behavioral data.

      The search for better analysis methods should certainly continue, and this preprint raises some important issues that we need to take into account when examining the results of papers measuring rhythms in behavioral data. Just like with neural data, we should ask whether what’s being called rhythmic—based on signal processing and averaging— actually looks rhythmic.

      To truly understand temporal structure in behavioral data, we need to link the behavior to its underlying neural data. When constructing evidence of temporal structure in behavioral data, each trial contributes a single data point (e.g., a hit or a miss) at a single cue-target delay. That is, a single behavioral time-series is constructed from numerous trials. With trial-level neural data, on the other hand, we can see the temporal dynamics associated with each behavioral response. That is, we can directly see evidence of periodic or aperiodic temporal structure in the neural data as well as the apparent influence of that temporal structure on behavioral responses.

      Taken together, I would argue that the previously published behavioral and neural studies make a strong case for a rhythmic (or periodic) structure in attention-related sampling.

    1. On 2018-05-03 17:55:43, user David Foutch wrote:

      Review of Miho, E., Greif, V., Roškar, R., & Reddy, S.T. from the bioRxiv Systems Biology:

      Title: The fundamental principles of antibody repertoire architecture revealed by large-scale network analysis.

      The authors investigate the reproducibility, robustness and redundancy of murine antibody networks. The authors use the sequence similarity of CDR3 B-cell receptor regions to construct networks from pre-B cells (pBC), naive B cells (nBC), and plasma cells (PC). Using a high performance computing platform the authors perform an exhaustive all-by-all sequence similarity analysis between CDR3 regions for each cell type pBC, nBC, and PC. The number of nucleotide differences determine the values of the i,j elements of the Levenshtein distance (LD) matrix (the adjacency matrix). From the LD matrix, the network was constructed. Sequences were identified as nodes and edges between nodes were generated by virtue of similarity, or LD. Similarity levels (denoted LD1-n) within networks were determined by edges connecting nodes with the same LDn values. Measures of network size, diameter, assortativity, degree distribution, node centrality (closeness and betweenness), network eigenvector, PageRank, transitivity, authority, clustering coefficients, and density were used to characterize each of the three types of networks. Then, by comparison across individual mice and similarity levels within each mouse, the authors made inferences regarding the reproducibility, redundancy, and robustness of the networks. The authors conclude that the methodology they employ demonstrate that the pBC, nBC, and PC antibody architecture networks of mice exhibit reproducibility, robustness and redundancy.

      Specific major comments:<br /> 1. The authors assume that the networks should be constructed from the sequence similarity of the CDR3 regions in the heavy chain. While it is generally assumed that these regions are most variable, this region is not the only source of variability in antibody diversity. Some discussion is warranted on whether similar results are expected to hold when variability in other regions and in the light chain, and in the paring of light and heavy chains are considered. Perhaps there are other justifications for this choice that would strengthen the argument for that restriction. <br /> 2. The authors suggest that the methodology reported in the paper may serve as a “blueprint for the construction of synthetic antibody repertoires and in personalized medicine. This seems like over-reaching. It isn’t clear from the references [32, 37-39] how the authors’ methodology can be integrated into the pipeline for synthetically designing antibody repertoires. The claim is made in order to rationalize the significance of the work. However, networks do not explain the underlying dynamics of biological systems. Therefore, this suggestion seems weak at best.<br /> 3. The biological significance of network parameters isn’t clear. For example, the authors report that the removal of public clones from the pBC and nBC networks shifted the degree distributions from an exponential to a power law. However, removing public clones from the PC networks failed to exhibit any shift in the characterization of the degree distribution. The authors interpret this to mean that ‘public clones are critical for maintaining the architecture of an antibody repertoire.’ How so? Are individuals with missing public clones more susceptible to range of infections? <br /> 4. Authors use multiple metrics, including some novel ones, to measure network structure (e.g., authority and PageRank of nodes). While these metrics are used in communication networks, their relevance to antibody networks needs to be justified. It is unclear what new information these metrics entail. <br /> 5. The finding that antibody repertoires between different mice are reproducible. Does this imply lack of stochasticity in B cell receptor generation? Is this consistent with what is observed in T cells?

      Minor points<br /> 1. There is appears to be overlap in CVs calculated (page 4) suggesting no difference in variability between pBC and nBC. Also, the definition of “large” and “small” in these settings seems arbitrary.<br /> 2. Memory plasma cells do not exist. It is either memory B cell or plasma cell.<br /> 3. The fact that fundamental principles of antibody structure are unknown and hinder profound understanding of immunity (line 41-42) is a clear over-statement.<br /> 4. The text would benefit from outlining basic steps in B cell development and how these steps impact expected Ab/BCR diversity to lay down potential expectations to the readers.<br /> 5. There is a lot of understanding about TCR diversity, public and private repertoire, and “holes” in the repertoire (e.g., PMID: 29080364, 26150657, 24172704, 21301479). Perhaps comparing results in this analysis with T cell analyses would be useful.

    1. On 2020-01-16 14:05:39, user Huashuai Xu wrote:

      My question is about the min(P) method: you use different CDTs, and then get different optimum cluster magnitudes (size or sum), next transform them into p-values, during each randomization, you save the minimal P-value from different CDTs, then get the distribution of min(P). My question here is how you make the final conclusion. I mean, according to the distribution of min(P), how can you judge if there are activated areas in the statistical maps?

    1. On 2021-09-20 11:39:13, user Clarissa M- maya-Monteiro wrote:

      Very interesting result. It really raises the question about the distribution of the fat depots. I would like to know why the authors did not perform these comparisons. Could also check for leptin gene expression in each of the adipose tissue depots.

    1. On 2020-09-02 22:37:17, user Patrick Sexton wrote:

      The structure of OWL-833 has not been released and therefore we cannot know with certainty if the compound synthesised and studied in our manuscript is this clinical candidate. <br /> As such, in the version that will be formally published, OWL-833 will be changed throughout to CHU-128; we use this naming to indicate that the compound is exemplar 128 in the patent series that includes OWL-833.

    1. On 2021-06-11 20:51:51, user Maria Izabel Cavassim Alves wrote:

      Thanks to Dr. Todd Jackman (Villanova), who emailed us a comment on our preprint, we have realized that there is an error in the distribution of TEX15 orthologs that we reconstructed: whereas we initially only detected the presence of a partial PRDM9 ortholog in Anolis carolinensis, there is in fact a complete TEX15 ortholog. As a result, the evidence for co-evolution of TEX15 and PRDM9 is less compelling (p-value = 0.058 in Table 1). We will be updating the preprint shortly to reflect this change.

    1. On 2019-07-09 23:57:59, user Charles Warden wrote:

      Thank you for posting this pre-print!

      Perhaps I need to sit down and try to take some time to read this (other) paper more carefully, but one thing that I thought seemed concerning was the use of imputation for rare variants (if I understood that correctly, with briefly skimming the paper): https://www.biorxiv.org/con...

      However, I think you are making a separate point about cluster generation (so, you directly measure the variant, but something that was called probably should have had a "no call" status), rather than issues with imputation in rare variants.

      I know that I was correctly identified as a cystic fibrosis carrier on the 23andMe SNP chip and incorrectly identified as not being a carrier with high-throughput sequencing from multiple companies (with the automated annotation --> I could look at the alignment .bam file and .vcf files to confirm that I was in fact a carrier with multiple technologies): https://github.com/cwarden4...

      So, for that reason, I don't want to down-play the overall use of SNP chips for carrier status diseases (or the possibility of needing re-analysis of raw data with high-throughput sequencing data), and I wonder if perhaps the sentence "extremely unreliable for genotyping very rare pathogenic variants" should be re-worded.

      Without the cluster generation files, use of raw .idat (or other format) raw data may be difficult if given access. However, could you separate probes that worked relatively better with other features (such as overall intensity and/or a more stringent call rate threshold)?

      Also, it looks like you are looking at Affymetrix and ThermoFisher arrays. What if you look at Illumina arrays (like used by 23andMe)? I guess 1000 Genomes data isn't really emphasized for rare variants. However, if you can get meaningful information about individuals like myself (with both array genotypes and high-throughput sequencing raw data), perhaps other resources like the Personal Genome Project can help?

      https://my.pgp-hms.org/prof...

      I don't know about rare variant coverage, but there are also some Illumina SNP chips in GEO (and dbGaP)? Since people making their 23andMe genotypes freely available on the Personal Genome Project won't give you access to raw data for re-processing, perhaps this would help with the question of systematically identifying the probes that you may want to filter?

    1. On 2018-06-19 19:10:03, user Brett Tyler wrote:

      Reading through Johan van den Hoogen's account, I was struck by two points.

      (1) The failure to observe GFP fluoresence from any of the Cas9-GFP constructs. I strongly suspect there is a problem with the production of hSpCas9 protein in P. infestans. Other versions of SpCas9 should be tried, as well as other Cas9 proteins. Until expression of the Ca9 protein can be confirmed I suspect most efforts will be doomed to failure.

      (2) No use was made of a transient expression assay (Fang 2016, Fig 2C) to check the activity of presumptive Cas9/sgRNA complexes. In combination with a restriction site at the sgRNA target site, the transient expression assay is extremely sensitive as it detects a restriction-resistant produce by PCR if there is NHEJ activity. Its possible that this might yield useful information, even if the Cas9-GFP production is not being observed. Note that the GFP should be left off for this assay.

      I hope these comments may be useful to those of you out there trying to get this to work.

    1. On 2020-06-25 09:44:32, user Joerg Gromoll wrote:

      Important piece of work. The authors are not detailing the isolation procedure for SCs and on the obtained purity. To me the cell culture fotos are not typical for mitotically quiescent SC and look more like fibroblast like cell type, which is highly proliferative ?

    1. On 2019-11-14 22:42:18, user Jubin Rodriguez wrote:

      In my opinion, an incomplete tutorial; for example, where is the R code for generating the volcano plots. Also, it is important to show on the plot or as a separate heatmap the names of some of the top upregulated or downregulated genes in the dataset under study.

    1. On 2017-10-16 15:43:59, user Kumaran wrote:

      "We expect based on our survey, that many data repositories already follow all required recommendations, but most need to do more work for those that are recommended or optional."- Could you provide the list of repositories that follow your recommendations? I see only number, I am curious to see how your recommendations are implemented in each data repository

    1. On 2023-09-15 11:11:29, user Dr Will Davies wrote:

      Congratulations to the authors on a really impressive and comprehensive piece of work with potential clinical relevance! These data are consistent with previous suggestions that CCN3 might be generally important in brain/placentally-mediated psychiatric and physiological phenotypes (specifically mood conditions and pre-eclampsia) occuring in late pregnancy/postpartum period: https://www.frontiersin.org.... I look forward to reading further work on this project!

    1. On 2020-01-08 17:41:04, user Thomas Weitzel wrote:

      IMPORTANT UPDATE: The most abundant chigger morphotype found in our study was re-classified as Herpetacarus species. For more information, please see the upcoming article.<br /> Thomas Weitzel

    1. On 2022-12-21 06:14:44, user Zhiyong Wang wrote:

      This paper has been accepted by The Plant Cell (a link to the paper will be available soon). About 2/3 of the BIN2-proximal proteins showed dephosphorylation upon bikinin or BR treatments, and thus are likely BIN2 substrates.

    1. On 2015-05-11 21:22:56, user David Schoppik & David Tingley wrote:

      Dreosti et. al. study social behavior in young zebrafish, focusing on its development, sensory origin, and sensitivity to drugs. Using a novel apparatus, they evaluate an individual fish’s preference to swim near one of two connected chambers that contains either a “social” stimulus (conspecifics) or remains empty. They quantify kinematic parameters, including time spent in each chamber, orientation relative to conspecifics, and the temporal dynamics of swimming in the presence of a conspecific. Taken together, their results validate an important novel assay of a behavior of broad interest in an appropriate model organism. Further, there are a number of interesting observations that set the stage for future experiments. The manuscript is appropriately circumspect in its claims, and nicely situates their findings within the broader literature.

      To our mind, the findings are generally sound. However, we have identified a number of areas where the authors may have inadvertently left resolving power on the table, or their choice of analysis simply isn’t clear. Below, we suggest a number of different ways to look at the data:

      1. Currently, the analysis of preference uses a value of 0.5 on the Social Preference Index as a cutoff for social/antisocial bias. We aren’t clear why the authors adopted this value, rather than one that specifically referred to the expected values from the distribution of SPIs during the acclimation period. Alternatives could be those fish with SPI that fall 2 standard deviations from the average during the acclimation period, or those that fall outside a 95% confidence interval.

      2. For the data in Figure 1, we infer that the distributions come from paired data (i.e. each fish had both an acclimation and a test period). If so, the appropriate test would be a paired t-test, not simply a two-tailed t-test as described in the Methods.

      3. We aren’t clear why the authors use “the same [t-test] statistic [sic] throughout” (Methods) when some of the data is clearly non-normal. The analyses are multiple comparisons of different populations. If the authors wish to use a single statistical analysis, than a non-parametric ANOVA using age as a factor with post-hoc tests would be preferable.

      4. In light of the possibility that fish can be both “social” and “anti-social,” it would make more sense to perform statistical analyses on the absolute value of the SPI, rather than the raw SPI. Consider the possibility that during the test phase fish were evenly split 50/50 with perfect SPI values of either 1 or -1. There, the mean would be precisely zero, which would not be different from the SPI during the acclimation period. Obviously, this would be an inappropriate conclusion. Such a split may explain the null finding in Figure 2d. Naturally, a non-parametric test would be appropriate here.

      5. When investigating the coordination between fry, the authors use the bout-triggered average. An ideal measure would report the probability of seeing a bout in one fry, as a function of lag from another — while taking into account the frequency of bouts in both fry. Such an analysis is common in signal processing, and is called coherence (Brillinger 1975, Halliday & Rosenberg 1999, or http://en.wikipedia.org/wik... ). Using coherence would allow the authors to report the relationship between the two as a true fraction of variance explained, rather than their complex trace that is arbitrarily normalized to the % of average bout. We note that the author’s “Bout Triggered Average” is roughly comparable to the numerator of the coherence equation.

      6. With the bout-triggered average, a metric in units of motion magnitude, directionality is left in question. With such a tight correlation in magnitude of motion between individuals, we are left to wonder if these animals are swimming in the same or opposing directions.

      In the finest ethological tradition, the authors explore a number of relevant aspects of the “social” stimulus. They find that both visual information (dark vs. light) and conspecific size/kinematics (1 wk vs. 3 wks) are crucial for the preferences. Similarly, the coupling between conspecifics is intriguing, although incomplete. We recognize that the space of stimuli is vast and many variations on these themes are possible. However, the following experiments would strengthen the manuscript:

      1. Multiple tests of the same fish. We note that the authors appear to agree in the Discussion. Particularly in light of the “anti-social” behavior, and the authors stated interest in investigating the neural underpinnings of the phenomena it is crucial to identify whether such observations reflect the statistics of a population of fish or something truly fish-specific. One manipulation might be to simply switch the three conspecifics to the other side, to see if the fish switch sides to follow the group.

      2. We would like to know about the time-course of the synchronization of bouts among conspecifics. This could be investigated by slowly dimming the lights during the time three week old fish are viewing a conspecific, and analyzing the time course over which the fish bouts decouple. We hypothesize that a short time constant for the synchronization to decay would reveal a strong dependence on continuous visual stimulation, while a long time constant would suggest that much of the coupling reflects the statistics of spontaneous movement.

      3. The question of tactile/vibrational cues remain unexplored. Partridge & Pitcher 1980 demonstrate that adult fish are capable of utilizing the lateral line to shoal. A mesh window, rather than a glass window, could be used to explore the role of such non-visual cues in social behavior in dark conditions.

      4. Did the authors examine the social dynamics of 3 week old fish, with older/larger fish? Does size play a role in the reported “anti-social” behavior?

      The authors make a number of claims that would benefit from a bit more detail:

      1. The claim is that a 45 degree angle relative to the conspecific chamber is best for viewing; it isn’t clear why this would be preferable to a 90 degree angle?

      2. Is Figure 3c discussed in the text?

      3. We are curious about the temporal dynamics of the time in the chamber. How often do fish switch chambers? Do the three week old fish leave the conspecifics? Do “anti-social” animals switch chambers more often? Is the bout frequency comparable in all parts of the apparatus?

      4. There appears to be a grammatical mistake in the last sentence of third paragraph of the introduction.

      Finally, we call the authors attention to the recent work of Maurizio Porfiri, whose work on zebrafish social behavior, including in the presence of alcohol, merits consideration in the Discussion. It may also be interesting to address the relationship between this behavior in two dimensions to the three dimensional world these animals have evolved to inhabit in the discussion.

    1. On 2019-11-20 17:02:26, user Julia wrote:

      Hi, nice work! Would love to try the protocol. What is the PH for the lysis buffer (100 mM Tris, 1% sodium deoxycholate, 10 mM TCEP, 15 mM 2-chloroacetamide)? Is pre-isolation of the membrane fraction not necessary?

    1. On 2019-11-21 18:35:39, user Guido Governatori wrote:

      Absolute non-sense. There are problems with the formula: 100 human-years corresponds to 75 dog-years. 90 human-years to 39 dog-years, 80 human-years to 22 dog-years, 75 human-years to 16 dog-years. <br /> 75 human-years is less than 10% increase of the human life expectancy rate they consider in the paper (70 years), while 16 is over 30% increase of Labrador life expectancy (12 years).<br /> Their figure 2D is already off chart of the stage of life classification.

    1. On 2016-02-25 00:05:06, user Meru Sadhu wrote:

      Thank you, David, for the kind words and comments. We agree that the most immediate applications of the CRISPR-based recombination mapping will be in unicellular organisms and cell culture. We also think the method holds a lot of promise for research in multicellular organisms, although we did not mean to imply that it “will be an efficient mapping method for all multicellular organisms”. Every organism will have its own set of constraints as well as experimental tools that will be relevant when adapting a new technique. To best help experts working on these organisms, here are our thoughts on your questions.

      You asked about mutagenesis during recombination. We Sanger sequenced 72 of our LOH lines at the recombination site and did not observe any mutations, as described in the supplementary materials. We expect the absence of mutagenesis is because we targeted heterozygous sites where the untargeted allele did not have a usable PAM site; thus, following LOH, the targeted site is no longer present and cutting stops. In your experiments you targeted sites that were homozygous; thus, following recombination, the CRISPR target site persisted, and continued cutting ultimately led to repair by NHEJ and mutagenesis.

      As to the more general question of the optimal mapping strategies in different organisms, they will depend on the ease of generating and screening for editing events, the cost and logistics of maintaining and typing many lines, and generation time, among other factors. It sounds like in Drosophila today, your related approach of generating markers with CRISPR, and then enriching for natural recombination events that separate them, is preferable. In yeast, we’ve found the opposite to be the case. As you note, even in Drosophila, our approach may be preferable for regions with low or highly non-uniform recombination rates.

      Finally, mapping in sterile interspecies hybrids should be straightforward for unicellular hybrids (of which there are many examples) and for cells cultured from hybrid animals or plants. For studies in hybrid multicellular organisms, we agree that driving mitotic recombination in the early embryo may be the most promising approach. Chimeric individuals with mitotic clones will be sufficient for many traits. Depending on the system, it may in fact be possible to generate diploid individuals with uniform LOH genotype, but this is certainly beyond the scope of our paper. The calculation of the number of lines assumes that the mapping is done in a single step; as you note in your earlier comment, mapping sequentially can reduce this number dramatically.

    1. On 2020-02-17 14:25:20, user Jonathan Bohlen wrote:

      Dear Cottrell et al,

      Congratulations for this interesting manuscript and thank you for submission to biorxiv for quick access to the scientific community.<br /> Having seen that you invited comments and criticism on the work on social media, I wanted to share my thoughts on the manuscript in an open review:

      In this work, you investigate the effect of ARF loss of function on protein translation. ARF acts as a tumour suppressor in the p53 pathway and ARF loss is a frequent mutation in human cancers. You nicely verify an increase in protein translation in ARF -/- MEFs. Then, ribosome profiling was carried out to determine translation efficiency of which mRNAs is specifically affected by ARF loss and they find TOP-motive containing mRNAs to be translationally upregulated upon ARF loss. You verify this finding very carefullyt for a set of TOP mRNAs using western blotting, qPCR and reporter assays. Furthermore, you show that p53 is required for the ARF mediated upregulation of TOP mRNAs and that loss of p53 copies the phenotype of ARF loss. Therefore, ARF likely activates TOP mRNA translation via the MDM2-p523 signalling axis. Finally, you aim to determine how ARF loss activated TOP mRNA translation by testing previously known TOP mRNA regulators. Unfortunately, the results in this part are inconclusive and no clear mechanism of action could be established.

      In figures 1 – 3 you determine the transcripts that are translationally regulated by ARF loss of function very meticulously. The experiments are well controlled and conclusive. I particularly applaud the complementary use of RNAi based ARF depletion and genetic ARF KO for the ribosome profiling, assuring the reader that off-target effects of either depletion method can be ruled out.

      One minor issue is the fact that SV40 mRNA levels of the luciferase reporters assay in figure 3F are apparently increasing and are very volatile. Did you test whether the DNAse digestion of transfection luciferase plasmid was efficient? (By running qPCR on the non-reverse translated total RNA?) If this is assured, then how is the apparent, dramatic decrease in translation efficiency of this control mRNA explained? Maybe the use of an endogenous 5’UTR that has no TOP motive would be a better negative control.

      In figure 4 you show that in the context of a p53 knockout, the previously detected phenotypes are not detected anymore, suggesting that ARF dependent TOP mRNA suppression goes via p53. In a related approach, in figure 6, you compare wildtype versus p53 -/- MEFs and find similar phenotypes as for the ARF -/- MEFs, further supporting the idea that ARF acts through p53.

      Finally, figure 5 is probably the only part of this paper that has some loose ends. In panel A and B you aim to determine whether mTORC1 activity is changed in the ARF -/- cells. There are a few issues with these panels:

      Ser2484 mTOR phosphorylation is not reliable measure of mTORC1 activity for multiple reasons. It does not differentiate between active mTORC1 and mTORC2. Additionally, it does not consistently correlate with mTORC1 activity as assayed by lysosomal co-localization or target phosphorylation. Even in this publication (19145465) where Ser2484 is investigated, p-mTOR Ser2484 is not affected by Rapamycin treatment in a consistent manner (Figure 2, compare to p-S6). Therefore, I would recommend against the use of p-mTOR as a readout of mTORC1 activity.

      The detection of phosphor-S6K and phosphor-4E-BP are well accepted ways of assaying changes in mTORC1 signalling but here, these don’t show any changes that would be deemed statistically or biologically significant.

      You could attempt to determine mTORC1 activity by lysosomal localization of raptor to show that indeed mTORC1 is activated upon loss of ARF.

      In panel D, you find increased levels of eIF4G1 protein in ARF depleted cells. This is interesting and might explain the upregulation of TOP mRNAs. If you were able to carry out a mild knockdown of eIF4G1 in these cells to bring the eIF4G1 levels back down to ~wildtype levels you could test whether the increase in eIF4G1 levels leads to TOP mRNA translation activation while avoiding cell lethality.

      Finally, as you conclusively show that the increased levels of LARP1 found in ARF LOF cells cannot activate TOP mRNA translation as strong depletion of LARP1 does not appreciably or consistently affect TOP reporter translation. Therefore, LARP1 should probably not be brought up as a possible or contributing factor for TOP mRNA translation in the discussion?

      It would be nice to indicate the phospho-residues probed by western blotting (e.g. p-mtor Ser2484). It appears that the labelling of panels D an onward is mixed up or even omitted.

      In summary, this is an interesting and thought-provoking work that significantly advances our understanding of ARFs function in the regulation of protein translation and potentially during tumorigenesis. While the story is so far open-ended, there appear to be a few possible explanations for ARFs effect on TOP mRNA translation.

      If mTORC1 signalling is indeed increased to a sufficient degree to affect TOP mRNA’s then this should be verified by the suggested or alternative experiments.

      If the increased levels of eIF4G1 are responsible for TOP mRNA translation up-regulation then a mild knockdown or knockout of one allele of eIF4G1 could be a good test for this scenario.

      Finally, the most thought-provoking possibility is that there is a novel avenue of TOP mRNA regulation. This would be the most interesting outcome, but likely also the toughest to figure out.

      I thank you again for the submission of this excellent work and am keeping my fingers crossed for successful peer-review and publication in the near future.

      Best wishes,<br /> Jonathan Bohlen<br /> PhD Student

      DKFZ Heidelberg, Germany

    1. On 2023-12-15 03:23:38, user IVAN PAVLOVIC wrote:

      I really enjoyed reading the paper and I believe it did an amazing job at breaking down the complex reality of synapse formation and maturation. The flow of the paper was great and the multi-perspective approach to understanding both the role of LRP4 and its pathway as a whole made a strong case for the stated claims. Here are some comments I had about the paper:

      1) Using both a rescue of the lrp4 -/- phenotype and the RNAi approaches in neurons and muscle to understand the role of LRP4 in synaptic formation and maturation was great. However, I believe the argument would have been even more convincing with the addition of additional figures demonstrating the success rate of RNAi inhibition.

      2) I thought the sizes of samples used were great but the sampling was a little confusing. Since multiple NMJs from the same larva were analyzed as independent data points, it brought up questions about the effect of the sampling on the results. To resolve this problem, I would recommend either averaging the data acquired from multiple NMJ from the same larva and using it as a single data point or using a different way of analyzing data such as using a nested ANOVA.

      Overall, I really enjoyed reading the paper and it provided great insights into the complexity of synapse formation and maturation as well as the role of LRP4 within it.